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ABSTRACT 
The introduction of the New Growth Path (NGP) and the New Industrial Policy 
Framework (NIPF) have created an opportunity for the industrialisation of 
indigenous medicinal and aromatic plants (MAPs Amarula (Sclerocarya birrea), 
Buchu (Agathosma betulina), and Pelargonium (Pelargonium sidoides) for job 
creation and economic development in South Africa. The aim is to create a locally 
sustainable industry which creates jobs as well as improvement of the balance of 
payments. The National Growth Plan highlights some of the opportunities for 
industrialization as well as creation of decent jobs. There is increasing pressure 
on the harvesting of wild indigenous medicinal and aromatic plants (MAPS). The 
establishment of a local pharmaceutical and nutraceutical industry for processing 
MAPS remains a challenge in South Africa and many low income countries. The 
objective of this study was to assess the challenges and their impact looking at 
particular species, Amarula, Buchu and Pelargonium by using structured focus 
group interviews with users in communities and businesses in KwaZulu Natal 
Province, Eastern Cape and the Western Cape. More data/information was also 
collected from key stakeholder companies including desk-top reviews. 
Data/information was analysed using the SPSS computer programme and the 
Atlas software to summarize data and the results. Graphs and tables were used 
where necessary.  
 
The qualitative research reported on some qualitative assessments and 
challenges facing the establishment of medicinal and aromatic plants in South 
Africa. Comparative findings from BRICS were also reported. The results of the 
study indicated that there is continuous exploitation of several medicinal plant 
species, for plant trade, from the wild and substantial loss of their habitat. The 
research identifies a number of challenges such as: poor standards for raw 
materials, lack of research and development linking industry driven revenues, 
demand exceeding supply, regulatory risk, community risk, lack of understanding 
of judicious agronomic practices, ethical challenges, liquidity risk as well as 
political instability fail to attract foreign direct investments. The research 
concludes that for the establishment of a viable local pharmaceutical industry, 
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beverage industry and nutraceutical industry with sustainable harvesting, there 
are serious hegemonic challenges which will require multi-stakeholder analysis. 
However, for the South African (SA) industry to be competitive, detailed feasibility 
studies need to be done comparing SA with other BRICS countries. There is also 
a need for the Research and Development to be strengthened. It must also be 
linked into industrial development in the industry. Furthermore there is a need to 
initiate the incentivizing of the pharmaceutical manufacturing to lower the cost of 
setting up the businesses in the industry and lessen the need to harvest from 
South African forests. Furthermore there is a need for programmes of production 
so that key species are given opportunity for cultivation and the attention they 
deserve to preserve these depleting resources.  
 
Keywords: Sustainable harvesting, economic growth, job creation, plant trade, 
commercialisation 
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CHAPTER 1 
 
1.0  INTRODUCTION AND BACKGROUND OF STUDY 
Medicinal and Aromatic Plants (MAPs), the lead crops which are the focus area 
of this study are Pelargonium, Buchu, Amarula in the Kwa-Zulu-Natal, Western 
Cape and Eastern Cape provinces. The MAPs (Pelargonium, Buchu, and 
Amarula) are botanical raw materials, also known as herbal drugs that are 
primarily used for therapeutic, aromatic and/or culinary purposes as components 
of cosmetics, medicinal products, health foods and other natural health products. 
They are also the starting materials for value-added processed natural 
ingredients such as essential oils, dry and liquid extracts and oleoresins. There is 
a clear industrial demand for MAPs (Amarula, Pelargonium and Buchu); because 
of the increased production of herbal health care formulations; herbal based 
cosmetic products and herbal nutritional supplements.  
 
In addition, traditional health care practitioners, traditional healers and 
consumers at the household level have all contributed to the demand for herbal 
medicinal products. Finished products made from medicinal and aromatic plants 
are increasingly prescribed and bought over the counter. Medicinal and aromatic 
plants and extracts have become essential for the export of products in many 
developing countries. The preference by consumers to have natural products has 
grown over the years, and these increases have allowed medicinal  aromatic 
plants to present a unique and niche market  base that exporters  are looking to 
increase in the developed economies. The potential uses of these herbs is very 
wide: colouring of food, tanning of leather, plant protection, making of poison 
arrows, for drugging fish for primitive means of catching them, as narcotics, 
aromatic substances, flavouring or seasoning, to production of gums and resins 
or as medicine (Vermeule, 1998). 
 
Medicinal and Aromatic Plants-MAPs in this study are (i) Amarula (Sclerocarya 
birrea), (ii) Buchu (Agathosma betulina) and (iii) Pelargonium (Pelargonium 
sidoides) these three plants are defined as raw plant materials and are also 
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referred to as traditional medicines. Extracts from these plants are also used in 
cosmetic, health products, in food products and natural health products. They 
can also be used as materials for processed products as natural ingredients such 
as dry or liquid extracts and oils. There is a demand industrially for MAPs 
Amarula (Sclerocarya birrea), Buchu (Agathosma betulina), and Pelargonium 
(Pelargonium sidoides (Amarula, Pelargonium and Buchu) due to the new focus 
and increase in interest in both health based medicinal and cosmetic products, 
healthy and nutritious formulations. The consumer’s awareness of traditional 
healers, herbalists and alternative health care systems has created a household 
level demand for traditional medicinal products. In recent times the final value 
added or processed products made from medicinal and aromatic plants are 
bought or prescribed over the counter in many pharmaceutical stores. 
 
Traditional and plant  medicines  have been for many decades used and have 
always played and continue to be regarded as key role players in  health care 
systems around the world. In many parts of the world indigenous methods of 
traditional treatments are part of the culture and have been the major method of 
therapy in those communities and have been known for effectiveness, which 
makes them socially accepted, economically viable and, often are the only 
source of therapy available. In civilised an uncivilised communities people mainly 
depend on subsistence agriculture and natural resources for their livelihoods. 
Medicinal and Aromatic Plants (Amarula Amarula (Sclerocarya birrea), Buchu 
(Agathosma betulina), and Pelargonium (Pelargonium sidoides) have always 
been the most important source of economic activity in rural livelihoods in South 
Africa. Health care facilities in these regions are non-existence because they 
collect medicinal plants from the wild which provide communities in the rural 
areas with self-employment   opportunities.  
 
Medicinal plants have healing properties and are therefore called medicinal 
plants and may also be referred to as healing herbs. In the plant kingdom they 
are divided into several similar groups, but the plant classification differs per 
plant species. Medicinal plants may be classified as annual, biennials, woody 
perennials, trees, climbers and shrubs. In this study, the focus is flowering 
3 
 
plants, trees and shrubs. Traditional healing is the medicinal practice of healing 
using plants. The western-modern medical systems treatment somewhat differ 
from traditional healing, but there are some similarities in the methods and partly 
treatments used. For example, the use of aloe vera to manufacture a gel 
application for treating sunburn and bruises and creating skin balms for skin 
care. The major difference in the two types of systems is that the western-
morden medicine uses synthetic medicines that originate or are modelled on 
compounds obtained mainly from medicinal plants. Therefore, the use of the 
medicinal plants used as a whole, or partly thereof as synthetic modelled. Their 
discovery originated from the long term practice of the traditional medicine.  
 
Livelihoods of populations in the modern society both urban and rural areas 
depend on a variety of wild plant products and from an even more different types 
of wild plant species which include species with aromatic and medicinal 
properties. The export trade value of medicinal and pharmaceutical plants 
globally is estimated at USD 2.2 billion annually with 45,000 – 70,000 species 
harvested from the wild. There are many important uses and trade of these plant-
based pharmaceuticals plants (MAPs) Amarula Amarula (Sclerocarya sirrea), 
Buchu (Agathosma setulina), and Pelargonium (Pelargonium sidoides). They 
also feature in both traditional medicine practices and in western-modern health 
care systems. In addition to the known medicinal properties, these plants can be 
used in food as flavours and in drinks as colourants. They are also used in 
cosmetic and beauty products as perfume and give colour to beauty products. 
They are also used as incense in different religious practices. In many 
economies pharmaceutical trades provides a sustainable source of income to 
millions of households who are involved in the collection of wild medicinal plant 
material with women usually playing the major role in the wild plant collection. 
Trade happens when these plants are supplied for industrial production to both 
small and large manufactures of a large number of medicinal and household 
products. To date there is little or no accurate information available about this 
trade but the indication is that trade is increasing nonetheless. A great majority of 
medicinal and aromatic plants MAPs which are in use for traditional medicinal 
practices and for trade are collected in the wild. Raw materials have also been 
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provided by wild harvests which are used in the pharmaceutical production and 
traditional healing products. This practice has led to declining populations of wild 
plants around the world. It is estimated that one in five of the world medicinal 
plant species are threatened by extinction due to unsustainable wild harvest 
(http://www.traffic.org/medicinal-plants). There are implications here that are 
associated with loss of habitats, extinction of species and their possible 
biomedical uses. It is understood that indigenous inhabitants are as endangered 
as the forest in which they live (Kaufaman, 1999). There seems to be a slow or 
no recovery in species that have been selected for monitoring. The majority of 
people in rural areas in South Africa live in extreme poverty. With those in sub-
Saharan Africa about 70% of the population survive by subsistence agriculture 
(Hellmuth, Moorhead, Thomson and Williams, 2007). Agriculture is a major 
contributor to the current economy of most African countries ranging from 10% to 
70% of the gross domestic product (GDP) with the slowest record of productivity 
increase in the world.  Medicinal Plant Trade figures from the province of 
KwaZulu-Natal in South African shows important hub for medicinal plant trade 
(Niekerk, 2005). 
 
1.1  The problem statement 
South Africa is rich in fauna and flora, as well as agricultural resources and 
therefore need to have viable MAPs. The good climatic conditions and plant 
material include indigenous plant species like Pelargonium. South Africa has a 
high percentage of unemployment and large number of the population residing in 
rural areas. South African Flora shows obvious signs of stress as a result of 
overexploitation (Niekerk, 2005).The MAPs (Amarula, Pelargonium and Buchu) 
industry has the opportunity to create a good and economic viable industry that 
could employ many people in the upstream and downstream of the value chain. 
Producers and investors in the MAPs industry require efficient methods of 
streamlining their production and processing methods. This study seeks to take 
an in-depth analysis of the value chain of selected MAPs namely (Amarula, 
Pelargonium and Buchu) and make recommendations on how to efficiently 
participate and grow the supply chain and the industry. 
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1.2  Objectives of the study 
The objective of this study is to identify and analyse constraints in attempting to 
participate in the global supply chain by farmers/harvesters of three selected 
MAPs (Amarula, Pelargonium and Buchu) to improve business income and 
profitability. This study seeks to explain and create a deep understanding of the 
value chain and how it links up with reliable markets from production to markets 
in the high-value plants in medicinal and aromatic plants (MAPs). The lead crops 
which are the focus area of this study are Pelargonium, Buchu, Amarula in the 
Kwa-Zulu-Natal, Western Cape and Eastern Cape provinces. The specific 
objectives are to: 
i) Analyse the value chain of the three selected species regarding the 
processes leading to the final processed products in South Africa  
 
ii) Analyse the value chain constraints and challenges of the production and 
harvesting, processing, marketing, distribution and the final sections of the 
value chain of the three selected MAPs 
 
iii) Analyse the constraints and challenges facing the selected MAPs and 
others in South Africa in respect of research, information/data, 
infrastructure, facilities/equipment, institutional and policy support  
 
iv) Provide policy recommendations for sustainable development and 
participation of the producer’s/harvesters of the selected MAPs to the 
global value chain 
 
 
1.3  Research questions 
Based on the aforementioned specific objectives, the following research 
questions were formulated: 
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i) Who does the production of MAPs (Amarula, Pelargonium and Buchu) 
based products in the value chain?  
 
ii) What are the challenges and constraints affecting the MAPs (Amarula, 
Pelargonium and Buchu) value chain and how these challenges can be 
addressed in order to improve the MAPs (Amarula, Pelargonium and 
Buchu) value chain used by the industry? 
 
iii) What are the constraints and challenges of the production and harvesting, 
processing, marketing, distribution and the final sections of the value chain 
of the three selected MAPs? 
 
iv) What are the major value chain constraints and challenges militating 
against sustainable economic development potential of MAPs in South 
Africa in respect of: research, skilled human resources, patency, 
legislation, information and data, infrastructure, facilities and equipment, 
institutional and policy support? 
 
1.4  Project justification 
South Africa’s development and employment needs depicts a cross benefit 
arising from agriculture according to the New Growth Path (NDP). There are 
areas in the industry that are considered as gaps and should be areas of focus 
which can be addressed in order for South Africa and its economy to leverage on 
the Indigenous Bio-Economy afforded by Medicinal and Aromatic Plants. South 
Africa has a high percentage of unemployment and large number of the 
population resides in rural areas. The MAPs (Amarula, Pelargonium and Buchu) 
industry has the opportunity to create a good economically viable industry that 
could employ many people in the upstream and downstream of the value chain. 
Furthermore, rural South Africa is characterized by high unemployment, limited 
skills, persistent poverty and a bleak economic outlook. Few rural jobs utilize 
financial or technological resources and are unproductive at low often below-
minimum-wage. South Africa’s mining and other industries are shedding jobs at a 
massive rate with many unemployed people returning to their rural homes where 
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there are little prospects of jobs. In the absence of alternative income sources, 
natural resources are rapidly being depleted; deforestation and erosion are 
widespread (Everpix, 2013).  
 
The study identified the challenges in the MAPs value chain that government and 
industry can address in order to grow the sector in both urban and rural settings; 
increase investment and funding support for research, innovation, and 
technology transfer and product development. This includes the need to adopt a 
sustainable approach to Medicinal and Aromatic Plants with the potential to 
benefit end users as well as to create opportunities for advancing development of 
innovative products, increasing support of services, and promoting 
commercialisation in this sector. Africa has numerous ecosystems and 
vegetation zones that support an immense diversity of native and naturalised 
plant species, estimated to be at least 40,000 species (Shackleton, 2009).  
The anticipated research project results and recommendations are as follows: 
 Make recommendations to policy makers which will assist in some of their 
goals. The South African government has committed to the Millennium 
Development Goals (MDGs) which requires government to improve 
livelihood in rural areas using economic development 
 Can be used by the industry and government organisations when planning 
according to their Medium Term Plan (MTP) and assist in Research and 
Development (R&D) 
 May stimulate awareness and provide information and further research 
and promote bankable business for the communities 
 Capture the indigenous knowledge and  processes and the use of the 
three indigenous species used in the research area  
 Document the unique information and innovation by the communities in 
the study area. 
 
1.5  Scope and possible constraints of the study 
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This study seeks to take an in-depth analysis of value chain in the MAPs 
(Amarula, Pelargonium and Buchu) industry and make recommendations on how 
to efficiently participate and grow this industry. The study covers three provinces 
where the leading plants which are the focus area of this case study are Amarula 
Amarula (Sclerocarya birrea), Buchu (Agathosma betulina), and Pelargonium 
(Pelargonium sidoides) grow indigenously. There are other MAPs species that 
grow in various parts of South Africa but the study focuses only on these three 
specific species and the specific area where the industry operates. The research 
project is limited to assessing results from the area that is being assessed and 
does not reflect the total industry and it’s potential. In order to accommodate the 
different nature of businesses and species in question there was variation in the 
questionnaires when presented to different respondents in the Amarula group 
interviews, due to language and content. 
  
The focus group research interview required translation of the process and 
questions; the translation services were done professionally and were reliable; 
none the less the questionnaire was developed in English. The kind of focus on 
my topic requires a lot of explanation and narrative as some of the subjects were 
not literate but extremely knowledgeable. The average number in a group 
interview was 40 and consisted of mainly rural women of which some of them 
were illiterate. At times the focus of the study was situational and focused in 
detail in each part of the value chain.  
 
Other parts focused on the financial viability of the business. As the primary 
researcher I recorded noticeable systematic difference when comparing the 
information provided by the companies interviewed and at times could not 
account for the variance; I had to be objective and look at the data as presented 
by the participants. Human resources were not enough to collect data readily 
even when it was available, due to cost and to the distance between each of the 
areas and the large number of people that were involved in the communities. 
There were challenges in getting things like financial statement or cost of setting 
up a business in the procurement of the plant material and the pharmaceutical 
plant due to confidentiality and the high risk of sharing specific information. 
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1.6  Outline of the thesis 
The thesis is organized into seven main chapters; Chapter 1 presents the 
introduction and background to the study, problem statement, objectives of the 
study, research questions, project justification, scope and possible constraints of 
the study. Chapter 2 provides relevant literature review on the South Africa 
MAPs industry and its challenges. Chapter 3 provides the description of the 
study area. Chapter 4 presents the methodology, which discusses the methods 
of data collection and data sources, the sampling and analysis techniques and 
ethical consideration. Chapter 5 presents and discusses the results of the study. 
Chapter 6 presents and discussion of the analysis of the data and information of 
study; while Chapter 7 provides conclusions and policy recommendations from 
the research. 
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CHAPTER 2 
 
2.0  LITERATURE REVIEW 
2.1  Introduction 
The objective of the paper is to establish the challenges and constraints on the 
value chain of South African Medicinal Aromatic Plants and highlight the 
importance of this sector both on the legislative front and economic development.   
According to Diederichs (2006) South Africa is estimated to have consumed 200, 
000 tonnes of medicinal material annually. South Africa was unable to provide 
adequate employment, unemployment rates in fact increased. The New Growth 
Path (NGP) specifically calls for more inclusive growth, and “heightened efforts 
to strengthen partnership among all economic role-players, proceeding from the 
understanding that each sector has a critical role to play in addressing these 
challenges” (NDP, 2010). Agriculture, Forestry and Fisheries are widely 
recognized as sectors with significant job creation potential and with strategic 
links to beneficiation opportunities (IPAP 2013). However, between 1994 and 
2012, the real contribution to GDP of Agricultural sector increased by only 29%. 
The OECD recognises South Africa’s agriculture sector as among the least 
supported in the world: South Africa’s Producer Support Estimate is currently 
3.2%, versus 4.6% for Brazil, 7.1% for the US, and 18.6% for the OECD global 
value chains offer many market opportunities for the agriculture sector though at 
present most value added occurs outside of Africa. The development of medium 
term projections for agricultural markets has been the core work of the OECD’s 
Committee (OECD, 2011). The agriculture sector employed 65% of Africa’s 
labour force and accounted for 17% of growth in African GDP between 2001 and 
2011 (World Bank, 2013).  
 
Of particular concern is the lack of attention to Research and Development 
(R&D) (Muhammad & Awaisu, 2008) in the MAPs industry. According to the 
2009/10  R&D survey conducted by Human Science Research Council on behalf 
of the Department of Science and Technology (the most recent survey for which 
the results are available on  the website of HSRC), agriculture  accounted for 
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only 6.9% of South Africa’s total R&D expenditure. Moreover, of all government 
expenditure on the sector, only about 7% went to R&D. In the new policy by 
government called Bio-economy Strategy Medicinal and Aromatic Plants will play 
a significant in the economic turnaround of South Africa (DST, 2014).  The 
strategy clearly defines the “Bio-economy” to encompass biotechnological 
activities and processes that translate into economic outputs, particularly those 
with industrial application. Within the South African context these may include, 
but are not limited to, technological and non-technological exploitation of natural 
resources such as animals, plant biodiversity, micro-organisms and minerals to 
improve human health, address food security and subsequently contribute to 
economic growth and improved quality of life (DST, 2014).   
 
Government policy has recorded the agro-processing sector as the largest 
manufacturing sector in employment terms, with 183,502 employees (IPAP, 
2011) and it contributes a significant 3.1% of manufacturing value added as 
percentage of GDP. Moreover the sector has been identified in the Industrial 
Policy Action Plan (IPAP, 2010) as one of the areas with potential to actualise 
Macroeconomic objectives as pronounced in the New Growth Path (NGP). A key 
characteristic of the agro-processing is its strong up- and downstream linkages. 
Upstream, the sector links to primary agriculture across a wide variety of farming 
models and products. Downstream, agro-processing outputs are both 
intermediate products to which further value is added and final goods that are 
marketed through wholesale and retail chains. They are further distributed to a 
diverse array of restaurants, pubs, shebeens and fast-food franchises making 
agro-processing critical for employment creation and poverty eradication.  
 
 According to Niekerk (2005) the increasing rarity and the continuous exploitation 
of several medicinal plant species from the wild and substantial loss of their 
habitats during past years have resulted in population decline. The author further 
notes that many high value medicinal plant species over the years have become 
extinct and will be depleted. Furthermore natural resources cannot meet current 
or foreseeable medicinal plant products (Niekerk, 2005).  However the primary 
threats to medicinal plants are those that affect any kind of biodiversity used by 
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humans.  According to the Population Connection report there are many other 
potential causes of rarity in medicinal plant species, such as habitat specificity, 
narrow range of distribution, land use disturbances, introduction of non-natives, 
habitat alteration, climatic changes, heavy livestock grazing, explosion of human 
population (Population Connection, 2006). 
 
Ewens (2004) states that the fragmentation and degradation the indigenous 
species’ population will result in genetic drift. Furthermore the population 
bottleneck according to Ewens (2004) will cause many species to lose their 
original habitat. Additionally, natural enemies (i.e., pathogens, herbivores, and 
seed predators) could substantially limit the abundance of rare medicinal plant 
species in any given area. Traditional medicine in terms of a culture-bound body 
of indigenous medical knowledge, belief and practices has provided the primarily 
plant-based foundation for many ethno medical systems which already existed 
long before the development of ‘scientific’ or cosmopolitan medicine.  
 
The demand by majority of the people in developing countries for medicinal 
plants has been met by indiscriminate harvesting of spontaneous flora including 
those in forests (Niekerk, 2005). As a result, many plant species have become 
extinct and some are endangered and are on the Red List in KwaZulu Natal 
being the most affected (Niekerk, 2005). As Africa’s population grows, demand 
for traditional medicines will increase, and pressure on medicinal plant resources 
will become greater than ever. While loss of habitat is the major factor 
contributing to the depletion of natural resources in Africa, collection of wild 
plants for traditional medicinal use is extremely detrimental to certain species.  
 
However, active ingredients  use in leaves, roots and bark may often  vary in its 
use and therefore the demand for the different parts of the plant and its supply 
can be commercially grown of the active ingredient duplicated  or substituted 
(van Wyk et al., 2012). According to the  Food and Agriculture  Organisation’s 
case study in KwaZulu-Natal (1998) the indigenous medicine market is based on 
indigenous plants that are generally harvested from wild plant stocks in KwaZulu-
Natal, neighbouring provinces and other countries. The plant stocks and their 
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harvesting are not managed and little cultivation takes place. The combination of 
high demand and the lack of any significant resource management and plant 
production have resulted in a decline in the supply of numerous indigenous 
medicinal plants (Mander, 1998). 
 
Niekerk (2005) notes that there are some constraints associated with the 
processing of medicinal plants which may result in reducing their 
competitiveness in global markets and which have to be remedied. Some of the 
general constraints with regard to medicinal plants and traditional medicine 
include indiscriminate harvesting and poor post-harvest treatment practices 
(Niekerk, 2005). For the commercialization of this industry there need to be an 
improvement in conservation and cultivation practices. According to Diederichs 
(2006) an estimated 26 500 tonnes of raw MAPs material where exported to 
Europe and 50 000 tonnes of raw MAPs material outside South Africa and Africa 
(Diederichs, 2006). 
 
 He argues that the medicinal plant resources may be doomed to extinction by 
overexploitation resulting from excessive commercialization, habitat destruction 
and other natural and man-made destructive influences unless energetic 
conservation measures are taken to ensure their continued availability (Niekerk, 
2005). This can be done through the establishment of medicinal plant gardens 
and farms for primary agriculture in support of commercial production in South 
Africa. According to the Indo Global Journal of Pharmaceutical Sciences (2012), 
a low number of medicinal plants currently being cultivated should be increased, 
in order to meet the demands of industry for continuous and uniform material 
supplies, and to take some of the pressure off medicinal plants originating from 
natural ecosystems. At present, commercial varieties have been developed for 
about 16 species, most of which are cultivated for export. Furthermore the 
journal states that much more needs to be done to select superior genotypes of 
many more species. However to achieve this initiative, it will be necessary to 
make extensive use of the network of nurseries and gardens in the country, in 
order to establish high quality plant supply systems. Wild-harvesting practices 
are presently highly sustainable and are likely to remain so (Mazid et al., 2012).  
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There has been capability building in India in recent years in the Research and 
Development sector of medicinal formulations involving plants and its 
compounds both in private sector (i.e. industry oriented) as well as government 
funded research. There are several private sector and government Research and 
Development institutions in OECD countries that have supported the successful 
commercialisation of MAPs and their products. 
 
2.2  The MAPs and traditional medicine of South Africa in comparison to 
BRICS countries 
The existence of traditional medicine depends on plant species diversity and the 
related knowledge of their use as herbal medicine. In addition both plant species 
and traditional knowledge are important to the herbal medicine trade and the 
pharmaceutical industry whereby plants provide raw materials and the traditional 
knowledge prerequisite information (Tabuti et al., 2003).  
 
India has one of the richest plant medical traditions in the world. It is a tradition 
that is of remarkable contemporary relevance for ensuring health security to the 
teeming millions. There are estimated to be around 25,000 effective plant-based 
formulations, used in folk medicine and known to rural communities in India 
(ITPO, 2001). There are over 1.5 million practitioners of traditional medicinal 
system using medicinal plants in preventive, promotional and curative 
applications. It is estimated that there are over 7800 medicinal drug-
manufacturing units in India, which consume about 2000 tonnes of herbs 
annually (Ramakrishnappa, etal 2002). The market for ayurvedic medicines is 
estimated to be expanding at 20% annually. Sales of medicinal plants have 
grown by nearly 25% in India over a period of ten years (1987-96), the highest 
rate of growth in the world (Masood, 1997).  
 
The basic uses of plants in medicine will continue in future, as a source of 
therapeutic agents, and as raw material base for the extraction of semi-synthetic 
chemical compounds such as cosmetics, perfumes and food industries. 
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Popularity of healthcare plant-derived products has been traced to their 
increasing acceptance and use in the cosmetic industry as well as to increasing 
public costs in the daily maintenance of personal health and well-being. In the 
dual role as a source of healthcare and income, medicinal plants make an 
important contribution to the larger development process, and can reduce 
unemployment in South Africa (Bell, 1984). The study noted that the 
respondents’ main income came from the sale of the products made from the 
harvested plants. 
 
Though the efficacy of herbals requires development of quality consciousness in 
respect of the evaluation related evidences, supplying the demand for botanicals 
and herbals is a booming business (Mukherjee, 2002). Recently even developed 
countries, are using medicinal systems that involve the use of herbal drugs and 
remedies. Undoubtedly the demand for plant-derived products has increased 
worldwide. The demand is estimated to grow in the years to come fuelled by the 
growth of sales of herbal supplements and remedies according to several 
surveys. This means that scientists, doctors and pharmaceutical companies will 
be looking at countries like China, India, etc. for their requirements, as they have 
the most number of medicinal plant species and are the top exporters of 
medicinal plants (de Silva, 1997). However, South African farmers/harvesters 
can exploit this new industry in order to grow the sector, create jobs and 
economic development as well as balance of payment. The cost of setting up a 
full value chain industry for MAP’s includes major investment in research and 
development in order for the country to best utilise its natural resource despite 
these hegemonic challenges discussed in research. 
 
 The study recommends the support for agricultural studies for commercial 
cultivation of indigenous species and the need for Research and Development 
for the conversation of extinct MAPs. Further research on this subject is needed 
to reap the benefits of this labour. In fact, agricultural studies on medicinal 
plants, by its very nature, demand an equally large investment and higher 
priority. Research in support of industrial development encompasses all activities 
ranging from the development of superior propagation materials, agro-
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technology, low cost and efficient processing technologies to improve quality and 
yield, new formulations to new products and the marketing of finished products.  
2.3  World market: Export opportunities of MAPs for developing countries 
The value of medicinal plants as a source of foreign exchange for developing 
countries depends on the use of plants as raw materials in the pharmaceutical 
industry. It provides numerous opportunities for developing nations to advance 
rural well-being. The global trade in medicinal plants is of the order of US$ 800 
million per year. Export statistics available between 1992 and 1995 indicate that 
India exported about 32,600 tonnes of crude drugs valued at $US 46 million 
(Dhar et al., 2002). China with exports of over 120,000 tons per annum (US$ 
264.5 million) and India with over 32,000 tons per annum dominate the 
international market. The annual export of medicinal plants from India is valued 
at R1,2 billion (Ramakrishnappa. etal, 2002). All the major herbal-based 
pharmaceutical companies are showing a constant growth of about 15 per cent 
or more, next only to Information Technology industry (Kumar, 2000). The 
turnover of herbal medicines in India as over-the-counter products, ethical and 
classical formulations and home remedies of Ayurveda, Unani, and Siddha 
systems of medicine is about US$1 billion with a meagre export of about US$ 80 
million (Kamboj, 2000). 
 
According to an estimate of World Health Organization (2002-5), nearly 80% of 
the populations of developing countries rely on traditional medicine, mostly plant 
drugs for their primary health care needs. Traditional medicine has served as a 
source of alternative medicine, new pharmaceuticals, and healthcare products. 
Medicinal plants are important for pharmacological research and drug 
development, not only when plant constituents are used directly as therapeutic 
agents, but also as starting materials for the synthesis of drugs or as models for 
pharmacologically active compounds (Mukherjee, 2003). During the last two 
decades, India has made massive investments on pharmacological, clinical and 
chemical researches all over the world in an effort to discover sti ll more potent 
plant drugs. About 250,000 living plant species contain a much greater diversity 
of bioactive compounds than any chemical library made by humans but only few 
17 
 
plants species have been systematically investigated for the presence of 
bioactive compounds. A few new drug plants have successfully passed the tests 
of commercial screening. 
 
The support for agricultural studies for commercial cultivation is needed to reap 
the benefits of this labour, as medicinal plants are threatened by overuse 
(Bodeke et al., 1997). In fact, agricultural studies on medicinal plants, by its very 
nature, demand an equally large investment and higher priority. Research in 
support of industrial development encompasses all activities ranging from the 
development of superior propagation materials, agro-technology, low cost and 
efficient processing technologies to improve quality and yield, new formulations 
to new products and the marketing of finished products. There has been 
capability building in India in recent years in the Research and Development 
sector of medicinal formulations involving plants and their compounds both in 
private sector (i.e. industry oriented) as well as government funded research. 
There are several private sector and government Research and Development 
institutions in India of which a few have been mentioned. 
 
2.4  Conserving MAPs for drug/health care development  
The global craving for more herbal ingredients creates possibilities for the local 
cultivation of medicinal crops as well as for the regulated and sustainable harvest 
of wild. The expanding trade in medicinal plants has serious implications on the 
survival of several plants species, with many under serious threat to become 
extinct. Open access to medicinal plants in the wild is perhaps one of the main 
reasons for the current unsustainable levels of harvesting. As the prices paid to 
the gatherers tend to be very low, commercial plant gatherers often ‘mine’ the 
natural resources rather than manage them, as their main objective is to 
generate an income resulting in destructive harvesting (Bodeke et al., 1997).   
 
Other factors contributing to unsustainability include lack of sufficient data on 
wild plant populations, marketing, and trading; inadequate regulations and legal 
protection (including intellectual property rights for local practitioners with local 
18 
 
knowledge); and poor access to appropriate technology for sound harvesting and 
plantation development. Suggested actions to be taken to remedy the situation 
include: 
• Interaction between social, economic and ecological systems is most 
essential to conserve the medicinal plants making its sustainable use.  
• A need-based research including screening of plants for biological activity 
and focus on environmental and bio-diversity conservation aspects of forests, 
which continue to be primary habitats of medicinal plants, is desirable.  
• Training to the collectors and growers proves very useful in improving the 
quality of the material and plummeting the wastage (Bodeke et al., 1997). 
There is an urgency to have clearly defined policies to regulate medicinal 
plant conservation, cultivation quality control standards, processing and 
preservation, marketing and trade including domestic and export, and a well -
coordinated information network effort (de Silva, 1997). 
A major factor impeding the development of the medicinal plant based industries 
in developing countries has been the lack of information on the social and 
economic benefits that could be derived from the industrial utilization of 
medicinal plants. Except for the use of these plants for local health care needs, 
not much information has been available on their market potential and trading 
possibilities. As a result, the governments or entrepreneurs have not exploited 
the real potential of these plants (de Silva, 1997). 
  
2.5  Conclusion 
 In this chapter I looked at the international opportunities in MAPs for exports in 
South Africa in comparison with BRICS countries. Although most of the market 
for MAPs in outside where it is harvested, some of the BRICS countries like India 
have made massive investments on pharmacological, clinical and chemical 
research. In order for South Africa to further promote commercializing of this 
industry and be able to grow the industry in particular in Pelargonium, Buchu, 
Amarula in the Kwa-Zulu-Natal, Eastern Cape and Western Cape similar 
programmes will be an advantage. Furthermore it is clear with the increase in the 
harvested MAPs export the protection and conservation of medicinal plants does 
not take high priority on the agenda for natural resources management in South 
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Africa and in BRICS countries. Government programmes give priority to 
agricultural and wildlife resources, this is mainly due to the identified potential of 
such resources in contributing positively to national development. On the other 
hand, it could be because there is more information about agricultural, forestry 
and wildlife resources as compared to medicinal plants. This status will change 
as the profile of Medicinal and Aromatic plants extracts have become essential 
part of exports in the developing countries.  
 
The preference by consumers to have natural products has grown over the 
years, this increases annually and has allowed medicinal,  aromatic plants to 
present a unique and niche market  base for pharmaceuticals, cosmetics and 
other industries such as food & industrial use.  
 
.  
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CHAPTER 3 
3.0  THE STUDY AREA 
 
3.1  Introduction 
This chapter focuses on the three study areas selected for the study; it is divided 
into eight sections and analyse each of the MAPs characteristics by describing its 
use and the benefits. Presented in the chapter are the description of the three 
provincial areas relating to their rainfall, soil, slopes, altitudes, vegetation, maps for 
the demarcated areas of the research and main economic activities using graphs, 
plates and tables. 
3.2  Buchu Growing Area in the Western Cape Province 
The company which is a respondent in the study, sources Buchu from the 
Western Cape. Buchu occurs on damp lower slopes of the mountains of south-
western Cape from Tulbagh to Riversdale (Figure 1). In nature it prefers the 
middle slopes, particularly on saltier valley or shallow soils and often near water. 
Natural distribution is Mountain Fynbos. According to the 2011 census the 
municipality has a population of 52,642 people in 15,873 households. In South 
Africa Buchu is endemic to the mountains of the Western Cape. Buchu plants 
start to grow during August when the days start to become longer and 
temperatures increases after winter. It is also the time when rainfall starts to 
decrease. It is found in a small town called Clanwilliam in the north of the 
province, and in Stanford in the south, and east as far as the Outeniqua 
Mountains. This is called the Fynbos strip of the Cape; it is a Mediterranean type 
of climate which is dry in summer and rainy in winter. Buchu is in the citrus p lant 
family Rutaceae, with its genus being Agathosma. Buchu plants grows naturally 
on steep slopes with altitudes that range between 737 m to 2 028 m above sea 
level. This is the historical Khoesan area before the introduction of the western 
culture this was know as Barosma. The soils are mostly nutrient poor sandy soils 
with low pH varying. In the fynbos areas rains comes from June until spring.  
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Source: Demarcation Board (www.demarcation.org.za) 
Figure 1: Map of the Western Cape area where Buchu grows  
 
3.3  Amarula Growing Area in Kwa-Zulu-Natal 
Mtikini, Uthungulu, Umkhanyakude, Zululand, Northern KZN are Amarula areas 
in the deep rural areas of KZN (Figure 4) and supply the Amarula Company with 
Amarula dry kernels from the fruit in order for the company to press the oil. The 
areas where Amarula currently grows wild includes Umkhanyakude, Uthungulu 
and parts of Zululand; this largely rural area spans 26,453sqkm, and exhibits 
unemployment rates exceeding 42%. Planting trees and building the rural 
processing industry has the potential to positively impact the livelihoods of 1.55 
million people of 351 000 households, with poverty rates of, 62.5% in Uthungulu 
and 81.2% in rural Zululand adult income below R5057/annum (Census, 2010). 
African Conservation Trust (ACT) already planted 11,100 trees in Mphola village 
and rural schools, of which 7,000+ are Amarula and 4,000 Jackalberry (Papea 
capensis), another indigenous fruit bearing tree with oil-containing seed to share 
the same value addition paths. Expansion to additional rural communities and 
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areas will be in line with growing market demand. The areas where the trees 
grow are close to the homesteads of the communities. During the time of the 
study the communities handpicked the fruit in the local indigenous forests and 
dried it under trees in their homes.  
 
The transportation of the fruit is via large containers and wheelbarrows. The 
communities have developed a tool to pick the fruit and have methods of 
pressing and squeezing the fruit to get the most pulp out of the fruit without 
damaging the kernel which is dried and sold as a secondary income after beer is 
processed. The KwaZulu-Natal province, popularly known as KZN, is one of the 
nine provinces in South Africa. It has the second largest provincial economy and 
manufacturing sector in South Africa following after Gauteng, but it is the 
country's third-smallest province, taking up 7.7% of South Africa's land area. The 
KZN population has grown to approximately 10,645,400 people in 2010 from 
approximately 9,557,165 people in 2001 (Stats SA, 2010). The year-on-year and 
quarter-on-quarter growth rates for Gross Domestic Product (GDP) for South 
Africa and Gross Domestic Product for Region (GDPR) for KwaZulu-Natal are 
shown in Figure 2 and 3. 
 
Years (1995 -2010) by Quarter   
Source: Stats SA (2010) 
Figure 2: Year-on-year growth rate for GDP in South Africa and GDPR in KZN 
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Years (1995 -2010) by Quarter   
 
Source: Stats SA (2010) 
Figure 3: Quarter-on-quarter seasonally adjusted growth rate for GDP in South 
Africa and GDPR in KZN 
 
 
It is evident from Figure 2 and 3 that the South African economy as well  as the 
KwaZulu-Natal economy are recovering from the global economic recession. 
Statistics South Africa (2010) states that “a comparison of the average real 
economic growth rate from 2002 to 2009 recorded by the provincial economies 
and the total economy” shows that the “South African economy recorded an 
average growth rate of 3.7 % which KwaZulu-Natal bettered at 3.8 percept. 
Therefore this provides the right climate for economic growth in the MAPs 
(SARB, 2010). 
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Source: Demarcation Board (www.demarcation.org.za) 
Figure 4: KwaZulu-Natal Districts Map 
 
3.4  Pelargonium Growing Area in the Eastern Cape 
This Pelargonium species (Plate 1) is found in the southern regions of the 
Western and Eastern Cape (Figure 5). The distribution is the mountain ranges 
from the Swartberg Pass in the Oudtshoorn area eastwards to as far as Katberg 
in the Fort Beaufort area, a distance of more than 400 km. It prefers fairly moist 
habitats, and this explains its distribution pattern, as the mountainous regions 
experience higher rainfall than lower lying areas. Linctagon is a popular cough 
Syrup which is made from Pelargonium (Plate 2). 
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Source: University of Cape Town website (www.uct.ac.za) 
Plate1: Pelargonium growing wild in the Eastern Cape 
 
 
Source: University of Cape Town website (www.uct.ac.za) 
Figure 5: Eastern Cape Map, the dots show where Pelargonium grows 
26 
 
 
 
LINCTAGON SYRUP  
Linctagon Syrup contains Pelargonium sidoides to support the body 
to counter colds, flu and respiratory infections. The syrup can be 
administered to children of six months and older and contains the 
extract of Pelargonium sidoides. Pelargonium extract has been used 
as an herbal remedy in South Africa for many years and found its 
way to Europe in the early 1800’s. Numerous studies have been 
conducted on the efficacy and safety of Pelargonium in supporting 
the body to counter colds, flu and respiratory infections. In broad 
terms Pelargonium assists the body to shorten the duration of 
infections and to reduce the severity of symptoms. It displays both 
anti-viral and anti-bacterial properties.  
www.afliplex.co.za 
 
Source: Afriplex website adverts of a Pelargonium products 
Plate 2: Linctagon is a popular cough Syrup which is made from Pelargonium  
 
3.5 Group Environment and Company Environment 
The group interviews were conducted in a classroom style due to the number of 
the participants. The participants were mostly illiterate but very excited to 
participate in a study of this nature and were happy UNISA is doing the study. 
The company interviews where done in one on one meetings. Each interview 
was done in the language of comfort for the participants. The company 
interviews where done in a casual environment such as hotels. 
 
The sample group of 88 constituted of women between the ages of 25 and 72 
(Appendix 2). There were varying levels of economic activities but 92% of the 
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women were not formally employed. The socio-economic status of most of the 
women was the average rural living from hawking and seasonal trade in MAPs. 
The women relied on the MAPs for their livelihood. There were 54% of the 
women above the 55 year age group and 46% were between 25-55 years. The 
women noted that child bearing age women were faced with the challenge of 
child care which made it difficult for them to participate in the harvesting activities 
and making beer. There were no males in the group. Three of the women who 
participated in the study were traditional healers. The traditional healers were 
frequent harvesters of the plant material in the forest and therefore participated 
in the picking of the fruit during the season, 
 
3.6  Value Chain Analysis  
3.6.1  Introduction 
 This section of the chapter deals with the Value Chain analysis for sustainable 
economic development potential of South African aromatic, beverage and 
medicinal herbs in South African. Of the 68 vegetation types in South Africa, 
there are 22,000 species of vascular plants, of which 80% are endemic. 
Approximately 3,000 species are of medicinal value and are used by an 
estimated 200,000 indigenous TMPs. Most of the medicinal plant material is 
sourced from wild collection. Only a few medicinal plants are cultivated. The 
cultivated species include Warburgia salutaris (Bertol. f.) Chiov., Siphonochilus 
aethiopicus (Schweinf.) Bl. Birtt. and Agathosma spp. The practice of over-
harvesting and habitat destruction has endangered the existence of many 
medicinal and aromatic plants of high commercial importance. The endangered 
plants are Siphonochilus aethiopicus (Schweinf.) Bl. Birtt., Warburgia salutaris 
(Bertol. f.) Chiov., Ledobouria hypoxidoides, Mystacidium millaria, Ocotea bullata 
E. Mey. and Aloe ferox (L.) Burm. f. Siphonochilus aethiopicus (Schweinf.) Bl. 
Birtt. is a slow growing plant with limited distribution and its demand exceeds 
supply. Warburgia salutaris (Bertol.f.) Chiov is the most valuable traditional 
medicine. 
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About 95% of the resource base of Ocotea bullata E. Mey has been depleted for 
its bark. Aloe ferox (L.) Burm. f. is a species of international importance in the 
cosmetic and personal care products industry. The unsustainable and intensive 
harvesting from wild stocks is a serious threat to the biodiversity of medicinal 
plants in South Africa and its neighbouring countries. There is a lack of 
significant resource base management, and plant production and economics of 
associated markets. The conditions at the markets are generally poor. The lack 
of storage facilities and trading infrastructures frequently results in spoiled raw 
material as well as wastage and deterioration of the products quality. There is no 
legislation regarding the registration and certification of traded products. The 
processing and development of products is extremely limited. Value addition to 
the products and efforts to ensure standardization are scarce. The entire industry 
uses simple technology. 
 
The scarcity of popular plants has led to their undersupply, with considerable 
increase in product prices, imports and use of substitutive plants. Furthermore, 
there has been an increase in the use of destructive harvesting techniques, 
which aim to maximize the harvest from declining plant stocks in order to 
maintain income levels. 
 
3.6.2  Value Chain of Amarula tree 
The Amarula is a handsome, spreading tree of wooded savannah, and belongs 
to the mango (Anacardiaceae) family. It favours sandy soils in the warmer, 
eastern parts of the continent, where it may grow up to 15 metres in height. Few 
African trees are held in such high esteem by indigenous people; the Amarula 
has a multitude of uses in terms of diet and culture. The fruit is very high in 
vitamin C; it is the source of jelly and jam as well as the basis for potent liquor. 
These have been commercialized in recent times as 'Amarula Cream' - one of 
South Africa's most successful exports. The Amarula is a tree which belongs to 
the Mango (Anacardiaceae) family. Its scientific name is Sclerocarya birrea. It 
grows in sandy loam soils and in the warm eastern parts of South Africa. The 
tree grows up to 18m high. Leaves are compound, crowded near ends of 
branches, leaflets ovate to elliptic; fruit yellow 30-35 mm in diameter (Retief, 
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1997). Indigenous people hold this tree with high regards. It has a number of 
uses for indigenous people and forms part of their culture and diet.  
 
The MAPs in the case of Amarula (Sclerocarya birre)   source of the products is 
forest harvesting. The ripening of the fruit occurs in the South African Summer 
season (December – March). The harvesting is done early in the morning and 
late in the afternoon with 20kg buckets. There is a tradition from the past for 
harvesting Amarula from the forest. Production has not been developed because 
the demand and the supply are sufficient in this region. The harvesting is done 
daily until the season comes to an end. The fruit is picked from the ground and 
sometimes the harvester has to shake the tree to induce the fruit to fall. The fruit 
of the Amarula tree is very high in vitamin C and fibre. It is used to make jelly, 
jam and liquor by many households. There is successful export liquor products 
called Amarula Cream which is manufactured in South Africa using the Amarula 
tree fruit.  
 
In South Africa Amarula has many uses in the household environment which 
includes beer making that has a formal commercial business interest in women. 
Some of the products made from Amarula include wine. The female trees 
produce pale green fruits in February and March which is the late summer 
months. The fruit is 35mm in diameter and is oval with greenish tinge. The fruits 
fall and ripen in to a perfect golden yellow colour with a sweet flavour and smell. 
This yellow fruit which is rich in vitamin C has the strength of 8 oranges with 
Vitamin C with a tatty-sweet flavour. The inside of the fruit contains small thick 
walled stone which have a nutty flavour and are sought after for their oily seed. 
The fruit stone is dried and used in the processing of essential oils. 
(http://en.wikipedia.org/wiki/Sclerocarya_birrea). 
 
The Amarula fruit is collected in large quantities and is piled up in stashes for 
ripening.  The fruit is used is used for making local beer and jam in the 
communities.  The traditional beer is made by soaking fruit in water in an airtight 
container for a few days, and then squeeze out the fruit juice from the softened 
fruits. The juice is left in the airtight container for a further few days. After a few 
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days the beer or wine is ready and known to have a kick. It takes around 200 
fruits to make a litre of the alcohol. The jam is made by boiling peeled and 
cleaned fruit with a little sugar as the ripe fruit naturally sweet, once cooked the 
fruit is shredded and remains in the juice which is brought to boil to further 
reduce the liquid. Once cooled the jam is left to set. Large quantities of fruit are 
collected when they are ripe by mainly rural women. These include making 
alcohol which is the common practice; other products include jam and juice. 
(http://www.wildwatch.com/living_library/plants-1/the-Amarula-tree). 
 
A tree can produce 10 000 fruit pieces; beside the edible fruit Amarula is known 
for its oil rich nutty kernel seeds, which is sort after by humans and animals.  The 
stone like kernel is difficult to work with. The oil is used to preserve meat; some 
people in Venda use it to message the body. The Amarula fruit has no global 
footprint but in Southern Africa it has socioeconomic significance and is used 
traditionally for food.  The high protein fatty seed kernel is used for Amarula oil 
which is used in cosmetic products, in skin care oils and as a food in many 
households. This oil is known for its nutty flavour and contains antioxidants in its 
oleic acid. The tree’s bark has been used as prophylaxis for Malaria. The inner 
bark is known to treat insect bites, snake bites and is applied in scorpion bites to 
relieve pain. The leaves assist with heartburn and other gastric ailments like 
indigestion and stomach ache, when the leaves are dried and made into tea 
(Mudau et al., 2014). The dried up kernels are used in art and craft to make 
ornamental beads and other craft ornaments.  
 
The bark and gum of the tree has hue that when dried and processed is used as 
ink and a red-brown dye from the tannin rich bark is made for colouring  craft and 
household made paint for paintings. In agriculture livestock farmers use an 
infusion of the fruit to combat tick infestations and as insecticide for crop farmers. 
The wood is used in floor panels, boat building, sledges, furniture and drums. 
The inner bark can make ropes, yokes and other string instruments. Due to its 
well-known alcoholic capacities, rumours abound as to the Amarula's intoxicating 
effects on wild animals. While elephants and baboons both relish the fruit, the 
former would need to consume prodigious amounts of already fermenting fruit for 
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it to have even the mildest impact, and since these huge animals drink up to 160 
litres of water a day, there would anyway be a major diluting effect. Interestingly, 
examination of fresh elephant dung show that less than ten percent of Amarula 
fruits are actually 'processed' in any way - most fruit passes through the digestive 
tract intact.  
 
Amarula juice is made in the factory by processing ripened fruit that has been 
handpicked. The fruit is made into fruit pulp. The fruit pulp and fresh fruit juice is 
expressed and is packed din bags and frozen ready for distribution. Markets for 
the juice are local and brands like Ceres have developed flavours with Amarula 
as one of their flavour range. 
 
Amarula oil is made by cracking the nut using specialised technique and 
equipment. The machinery is labour intensive and uses the filter technique to 
extract the oil. The cracked nut results in a soft kennel which are collected and 
pressed to get the precious Amarula oil. The oil is cold pressed to preserve the 
active ingredients. The market for Amarula oil is mostly export and the local 
cosmetic and pharmaceutical industry. Amarula oil is edible and has been used 
in the culinary industry and speciality oil for cooking and baking. 
 
The beer is usually micro-brewed using ripped fruit that has been washed and 
peeled to expose the fleshy fruit. The skin and fruit and pips are covered in water 
and put in an airtight container for 2-4 days after which the mixture is strained 
and further fermented for 2 to 4 days. The fermented mixture is further strained 
and packed in bottles and chilled. 
 
In producing Amarula cream liquor, the fruit is pulped and fermented then it is 
slowly distilled to produce a concentrated flavourful Amarula spirit. The spirit is 
wooden matured in French oak barrels for 2 years after which fresh cream is 
added to finish the product. 
 
To produce Amarula jam, the washed ripen fruit (Plate 3) is peeled and boiled 
with some pectin rich green fruits. The mixture is strained and sugar is added 
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with lemon juice. The mixture is further boiled and cooled bottled and labelled 
when cool. 
 
 
Plate 3: Harvesters handling Amarula fruits in bags 
 
3.6.3  Value chain of Buchu 
The most commonly used species of Buchu for therapeutic purposes is known as 
Agathosma betulina formally called Barosma betulina. Barosma crenulata (also 
known as Agathosma crenulata (Ovate Buchu) Barosma serratifolia (Long 
Buchu). All species of Buchu belong to the Rue (Rutaceae) family - the same 
family as Citrus Fruits. Other Names: Boegoe (Afrikaans), Boochoo, Bookoo,  
Bucku, Bucco, Diosma, iBuchu (Xhosa), Short Buchu. It is a five foot shrub (Plate 
4) with finely toothed opposite or alternate leaves 3,5cm long. The leaves have 
visible oil glands that release a strong aroma reminiscent of blackcurrant. It has 
white flowers with purple anthers which appear in spring, usually with 5 petals. 
Buchu is a low, white or pink-flowered shrub native to South Africa. This species 
is sometimes confused with Agathosma crenulata but in the latter the leaves are 
more than twice as long as they are broad.  
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Plate 4: Buchu plants in the Western Cape 
 
Native to South Africa, the word Buchu is from the Hottentot word for the plant, 
bookoo.  The leaves are mixed with oil and used as a perfume in Africa. Buchu is 
part of the cultural heritage of the San and Khoi people. Chemicals and 
Nutrients: Constituents include: Bioflavonoids: Hesperidin, Lipids: Limonene 
Terpenes: Terpineol. Volatile Oils, Barosma, Camphor, Diosphenol , 
isomenthone Menthol, Pulegone [compound considered to be toxic-found in 
crenulata]. Mucilage, Minerals and Nutrients. Aluminum, beta-Carotene,Calcium, 
Chromium, Iron, Magnesium, Manganese, Phosphorus, Potassium, Protein, 
Selenium, Silicon, Sodium, Vitamin C, Zinc.   Sulphur (Partly) responsible for the  
characteristic blackcurrant smell and flavour of Buchu oil. Essential oils are 
generally used because of their antiseptic and diuretic properties.  
 
Buchu has a restricted natural distribution area in the mountains of the Western 
Cape. Dosage Recommendations: Tinctures or infusions are used. A cup of 
boiling water is poured on 1g of the drug and allowed to stand for 10 minutes 
before straining. The infusion is taken three times a day. Buchu can be used as 
Antiseptic, Aromatic, Carminative, Diaphoretic, Digestive Tonic, Diuretic, Kidney 
Tonic, Stimulant, Tonic, Urinary Antiseptic, and Uterine Stimulant. Cold, Infusion, 
Tea, Tincture, Capsules. The leaves are steeped in brandy and the tincture 
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(commonly known as Buchu brandy or “boegoebrandewyn” was an everyday 
remedy for stomach problems. 
 
Buchu products (Plate 5) can be used to treat Arthritis, Bed wetting, Bladder 
Stones, Bloating, Cystitis, Oedema, Flatulence, Gonorrhoea, Gout, 
Hypertension, Incontinence, Indigestion, Kidney Inflammation, Kidney Stones, 
Nephritis, Prostate gland disorders, Prostatitis,  Pulmonary Oedema, Pyelitis, 
Pyelonephritis,  Respiratory disorders, Urethritis, Urinary Infections. It helps 
incontinence associated with prostate problems.  Buchu aids in the elimination of 
calculus debris, mucus, and uric acid from the kidneys. It soothes and 
strengthens the urinary system. Buchu can be used to influence the digestive 
system; it is used to treat minor digestive disturbances. In the excretory system, 
Buchu is reputedly helpful in the treatment of Kidney Stones. Buchu reputedly 
possesses diuretic properties that alleviate Urinary Tract Infections (UTIs). 
Buchu is employed by many herbalists in the treatment of Cystitis (the diuretic 
effects of Buchu are claimed to help to flush away the Detrimental Bacteria that 
cause bacterial Cystitis). Metabolism of Buchu helps to normalize Blood Sugar 
levels (primarily it helps to prevent rapid falls in Blood Sugar levels 
(Hypoglycaemia)) Musculoskeletal System Buchu reputedly alleviates 
Rheumatism. 
 
Plate 5: Buchu derived beverage, nuetricitical and pharmaceutical products 
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The properties of Buchu are that it is a stimulant, strong diuretic, antiseptic, and 
cleansing herb that increases perspiration. The antiseptic and strong diuretic 
properties are evident due to the active ingredient in the herb: disosphenol or 
barosma camphor. The leaves contain an essential oil which contains limonene, 
isomenthone, diosphenol (Buchu camphor), terpinen-4-ol and minor sulphur 
containing compounds such as 8-mercpatco-p-methane-3-one. The A. betulina 
leaf is more active than that of A. crenulata, as it contains low amounts of 
disosphenol, yet a possibly high toxic level of pulegone. Other therapeutic uses: 
internally for the relief of urinary tract infections, especially in conjunction with 
prostate problems. Furthermore, it is also used in the symptomatic relief of 
rheumatism. It is also used for bloating while menstruating, reducing high blood 
pressure, and congestive heart failure. Buchu is also used to decrease water 
retention. 
 
Buchu decreases inflammation of the colon, gums and mucous membranes and 
is specially used to treat bladder infection. External use: Steeped in vinegar it is 
used as a remedy for bruises and sprains. Aromatherapy and essential oil use: 
The oil extracted from Buchu should, (because of its high pulegone content) not 
be used in aromatherapy as it is considered toxic. Safety precautions and 
warnings: When using Buchu as a diuretic must be noted that it can deplete the 
body’s store of potassium. When taking Buchu, you should increase your 
consumption of potassium rich food in suppliments, such as banana, various 
dark green vegetables, whole grain and fish. Women who are pregnant or 
nursing should not take therapeutic amounts of Buchu and the herb should also 
not be used on young children.  
 
3.6.4  The value chain of Pelargonium 
Pelargonium sidoides is a medicinal plant native to South Africa. Its common 
names include Umckaloabo and South African Geranium. Root extract of 
Pelargonium sidoides is used as cold and flu medicine under various brand 
names including Kaloba, Umcka and Zucol. For hundreds of years the Zulu, 
Basuto, Xhosa and Mfengu cultures have used Pelargonium sidoides as a 
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curative for coughs, upper respiratory tract irritations and gastrointestinal 
concerns. Today, with the advantages of modern science and clinical research, 
we are able to better understand what makes this traditional remedy work so 
effectively. Pelargonium sidoides has been successfully used for the treatment of 
Respiratory infections like bronchitis, sinusitis, and pneumonia, tonsillitis and 
rhinopharyngitis. It is often used as an alternative to antibiotics, acute and 
chronic ear, nose and throat infections. Rapid improvement in the symptoms 
associated with colds and flu, Analgesic (absence of pain) effects. 
 
Pelargonium sidoides occurs throughout the Eastern Cape, Free State and 
southern and south-western Gauteng in the Republic of South Africa. 
Pelargonium sidoides is the name used by the Kalwerbossie or Rabassam in 
South Africa. However, the name Umckaloabo is the most commonly known and 
originates from the Zulu language "heavy cough". Pelargonium suburbanum 
subsp. Pelargonium suburbanum is a fast growing, showy, long flowering plant, 
an outstanding plant for rockeries, walls and steep slopes, an excellent ground 
cover in a sunny position in any garden, and is tolerant of coastal conditions. It is 
also suitable for hanging baskets, window boxes or tubs. It flowers from mid-
winter until mid-summer (the end of June into January), with a peak during early 
summer (October to December).  
 
The plants are not long lived and should be replanted after two years; when they 
tend to start dying off from the centre. However, they are very easy to propagate 
from cuttings and seed germinates readily. Stem cuttings may be taken in 
summer or autumn from a parent plant that is strong and healthy. The stem 
should be fairly firm but not woody, with at least 3 to 5 leaf nodes, and cut just 
below a node. The leaves and stipules should be removed leaving only a few 
leaves intact on the top. Large leaves may be trimmed to reduce moisture loss. 
The cuttings should be left to dry for a few hours before being placed in the soil. 
The cuttings should be rooted in trays or in cold frames, in well-drained medium 
e.g. coarse river sand.  
They can also be planted directly into the ground, as long as they are given light 
shade and are watered regularly until they have rooted. The basal ends of the 
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cutting should be dipped in a rooting hormone to improve the rate of rooting and 
inserted in a prepared hole made by a dibber or a nail to avoid damaging the 
ends. The cuttings should be watered regularly but kept on the dry side, as over-
watering will result in losses. After root formation has started, 4 to 8 weeks later, 
the cuttings should be fed with a seaweed-based fertilizer and potted up 1 or 2 
weeks after this. Plants produced this way will flower in approximately 3 to 6 
months.  
 
The Pelargoniums seed demonstrates interesting mechanism it has a feathered 
tail-like structure, which is coiled into a spiral. In a corkscrew fashion the tail 
causes the seed to be twisted around so that it drills into the soil. It then secures 
itself firmly in the soil. The seed is viable for 7 years and germinate when sown 
fresh. The seed grows well in soil that is well-drained, with high sand content. 
Sowing depth is usually one and a half times the size of the seed. Germination 
usually takes place within 10 to 14 days in temperatures  that are low, plants 
from seeds grow vigorous than those produced from cuttings; however, they take 
longer to flower, from 12 to 18 months after sowing, and  there may be variation 
in the above from different geographical areas  and climate. 
3.7  Conclusion 
This chapter I have been able to look at the three study areas selected for the 
research.  This chapter gave each species a general description, the topography of 
the growing areas and later a description of their medicinal, food, beverage and 
other uses. The chapter also analysed the value chain of the selected MAPs and the 
present characteristics of the 3 provincial areas relating to their rainfall, soil, slopes, 
altitudes, vegetation, maps for the demarcated areas of the research and main 
economic activities. In order to analyse the information and describe the area maps 
are used for the demarcated areas. Furthermore using graphs, plates and tables the 
analysis is made easy to understand.  
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CHAPTER 4  
 
4.0  RESEARCH METHODOLOGY 
4.1  Introduction 
This section describes the approaches and methods that this study employed. 
Sources of data, sampling procedure, data collection and data analysis 
techniques are briefly discussed. As a qualitative research study, it is presented 
in descriptive and narrative form rather than as a quantitative approach. 
 4.2  Data 
The study used both secondary and primary information/data. The research 
made use of secondary data from review of literature through a desktop study of 
published and unpublished sources. Secondary information was also gathered 
from annual reports from the Afriplex office, non-governmental organizations, 
research institutions and academic work of individuals. The information gathered 
from the desk review was also used to inform the selection of the sites for 
conducting focus group discussions and mapping the various key informants to 
be interviewed. This also informed the research in terms of existing information 
gaps and the identification of areas for further investigation. Focus group 
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discussions were used to gather primary information/data from key stakeholders 
in the industry in South Africa. Primary data/information was also gathered 
through interviews with officials from other departments both at provincial and 
district levels. 
 
4.3  Sampling method and sample size 
The participants were purposefully selected because of their unique expertise in 
the MAPs industry. The researcher conducted the pilot study using a structured 
questionnaire and unstructured interviewing techniques; asking-open-ended 
questions of the participants about their unique expertise in their respective 
MAPs use. The selection criteria for inclusion of companies included the size of 
the companies and the MAPs species used by the company. Non-probability 
sampling procedure was employed to sample farmers/harvesters. According to 
(Bless and Higson, 1995),  the idea of non-probability sampling refers to that 
case in which the probability of including each element of the population in a 
sample is unknown. Since most participants belonged to a group.  In a focus 
group, questions were asked in an interactive group setting where participants 
were free to talk with other group members (Marshall and Rossman, 1999). 
Group discussions produce insights that would be less accessible without 
interaction found in a group setting because listening to others’ verbalized 
experiences stimulates memories and ideas in the African tradition. When 
sampling, it is important to deal with an adequate sample size in order to collect 
accurate information about a group (Bless & Higson, 1995). A large sample is 
more representative but very costly; while a small sample is less accurate but 
more convenient. In all, three focus discussion groups were formed with sample 
sizes of 29, 22 and 40 per group. 
 
4.4  Data Collection 
The data was collected from smallholder farmers/harvesters and MAPs 
companies. This was done by means of an interview questionnaire as the data 
collection instrument. A structured questionnaire was also used so as to 
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interview respondents in order to standardize the order in which questions were 
posed to respondents, and to ensure that questions were answered within the 
same context. A protocol consisting of a written questionnaire, interpreted 
interviews focus group discussions and both e-mail and one on one interviews, 
was used to obtain the data. A focus group approach was used to interview the 
MAPs participants. In the group discussion the researcher used a non-directive 
style of interviewing using open-ended questions allowing the participants the 
freedom to control pacing and subject matter of the interview. Additionally, a 
more directive style of questioning was used as needed when the researcher 
required more clarification of information that the participants provided. The 
researcher recorded the information from the group to capture the key points and 
for hand-written notes. Reliability was assessed through test-retest 
reproducibility by asking some of the participants to complete the questionnaire 
on more than one occasion. A sample of interview questions is presented in 
Appendix A. 
 
4.5 Data Analyses 
All the data from focus group discussions, key informant interviews, secondary 
data and field visit observations was consolidated and analysed using the SPSS 
computer programme and the Atlas software to summarize the data. Information 
from the key informants’ interviews was used to triangulate information gathered 
from the desktop review and focus group discussions. Tables and graphs were 
used to analyse and present data/results where necessary. 
 
4.6  Ethical consideration 
According to Leedy and Ormrod (2010), most ethical issues in research fall into 
one of four categories: protection from harm, informed consent, right to privacy, 
and honesty. The researcher did everything within her power to protect  the 
participants’ physical, social and psychological welfare and to honour their 
dignity and privacy. The researcher kept high standard of ethics when 
undertaking the study. The participants were presented with a written consent 
form to describe the nature of research project and their purpose of participation 
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thereof as suggested by Leedy and Ormrod (2010). The aims of the investigation 
were communicated as much as possible to participants. The participants were 
given their rights to remain anonymous. Questions asked were not insulting or 
embarrassing. The privacy and wishes of informants were respected at all times. 
All the materials used were acknowledged through referencing. The researcher 
has an obligation to respect the rights, needs, values, and desires of the 
participants and did so by taking the following safeguards. The following 
safeguards were used to protect the participant’s rights:  
1) Participants were advised about the UNISA research towards the qualification 
being voluntary in nature partcipants could withdraw from the study at any time 
without penalty. They were also advised that at any time during the process they 
could decline to answer any question.  
2)  The researcher’s objectives were clearly explained before the interviews and 
group discussions.  
3)  A written consent form was given to each participant and signed, the group 
was requested to verbally consent also.  
4)  The participants were informed of all data collection methods and activities 
post the research and that the outcome will be shared with them. 
5)  Provisions will be made for monitoring the data collected to ensure the safety 
of the participants. 
6)  An interpreter was procured for collecting the data where English was not the 
first language. 
7)  The participant’s rights, interests and wishes were considered first when 
choices were made regarding reporting the data.  
8)  The risk to the participants was considered none existent to minimal.  
 
4.7  Procedural Rigor 
 
Qualitative validity was determined through the use of strategies to check the 
accuracy of the findings.  A triangulation from different data sources was used to 
build a coherent justification for the themes in the literature review.  
 
4.8  Conclusion 
42 
 
This chapter examines the methodology used in collecting the data in the research 
and the qualitative technique used in collecting data. The primary and secondary 
data collected suggests that the final results will meet the objects of the study. The 
population size means that the data collected is significant to draw the secondary 
data and make conclusions that will assist in the variety of research questions in the 
study. The ethical consideration and procedural rigor were done in order to ensure 
that this research meets the requirement set out by the academic department and 
UNISA. 
 
 
CHAPTER 5 
 
5.0  RESULTS OF THE STUDY AND THE INTERPRETATION 
 
5.1  Introduction 
This chapter presents the results and discussion of the descriptive analysis. The 
data under analysis was collected from three MAPs producing provinces in Kwa-
Zulu Natal, Western Cape and Eastern Cape with groups and individual 
companies in MAPs industry. The sections begin with brief presentation of the 
demographic characteristics of the participants of the study.  
5.2  Demographic characteristics of sampled MAPs farmers/harvesters  
In this section, aspects such as gender and age are discussed. This aspect of 
the chapter is important because the participants in value chain interviewed are 
the key focus in the commercialisation of MAPs for economic development in 
their provinces. 
5.2.1  Gender distribution 
In all the areas surveyed there were more females than males as shown in Table 
1. The women have the tradition of harvesting MAPs as it is culturally observed 
as a woman’s job. In some cases the women are not educated enough to get 
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better jobs in urban areas compared to their male counterparts, who can get 
work in mining in the cities. It is also a cultural phenomenon that traditional 
Amarula beer, Buchu remedies and Pelargonium remedies are made by women 
as the custodians of the technical knowledge and skill. 
 
Overall, when combining the three areas that were surveyed it was evident that 
more females are involved in agricultural activities as opposed to males. In total, 
there were 89.25% females and only 10.75% males in the areas studied as 
depicted in Table 1. 
 
Table 1: Gender of participants 
    Gender Focus Group 1 Focus Group 2 Focus Group 3 
Females 29 22 32 
Males 1  1 8 
Total 30 23 40 
 
5.2.2  Age distribution of participants 
Age distribution of the participants was fairly spread as indicated in Table 2 
below. The large majority of up to 36% of the sample were between the ages of 
50-64 years. The second largest age group was aged between 25 and 34 years. 
The lowest age group was the age group of younger than 24. The following were 
referred as the explanation for the low number of youth under the age of 24 
years: 
 Moving to cities by young people for better opportunities 
 The younger generation pursuing their studies to better their lives 
 Lack of interest in agriculture by young people 
 Lack of interest in traditional practices 
 Child bearing and lack of motivation due to grants from government 
Table 2: Age distribution of respondents 
Variable Number of  
MAPs 
 
 
% 
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Source: Used data from this study  
Groups 
>24 3  3.2 
25-34 26  28.6 
35-49 22  24.2 
50-64 33  36.3 
65+ 7  7.7 
Total 93  100.00 
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5.3 Results of Large International Company interviews – Western Cape;   
Cape Town Afriplex  
 
5.3.1  Introduction 
Afriplex harvest high-quality raw material from approved, sustainable resources 
and then transform these into a range of innovative, client-specific products and 
services. This is done through not only technologically advanced extraction, 
processing, purification and production methods, but also through constant 
research into consumer trends and keeping up to date with the ethno-botanic 
discoveries and applications. A variety of indigenous plant extracts are traded, 
although the main focus of the commercial plantings is Rooibos, Honeybush, 
Hoodia gordonii,  Buchu and a selection of African Aloe species. The suppliers of 
their raw material have to adhere to a stringent set of quality standards and are 
approved only after a rigorous quality audit by their Quality Assurance 
Department. Figures 6, 7 and 8 are annotated value chain diagrams of the three 
selected MAPs of the study.   
5.3.2  Production Process Section of the value chain 
 The company Afriplex employs two production methods of MAPs this includes 
wild harvesting for the Pelargonium, Aloe and Buchu. The company also 
engages in commercial production or propagation of Pelargonium, Rooibos and 
Buchu under tunnel production. The limitation with the raw material that is 
propagated and grown is that it has poor quality in chemical composition 
compared to the harvested material.  Afriplex as commercial farming enterprise, 
which focus mainly on Rooibos, Hoodia gordonii, Pelargonium sidoides, Buchu 
(Agathosma betulina) and a selection of African Aloe species, allows its clients a 
secure supply of these raw materials for their products. In some instances their 
clients can even choose to co-own such enterprises, to ensure long-term 
assurance for the supply and availability of quality raw materials.  
 
In the early 1970’s all plant materials were harvested, but over time the company 
invested in commercial technical expertise to be able to have a sustainable 
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business model and grow the business with the demand. The biggest challenge 
has been the quality of the commercially grown material in relation to the 
harvested material. The harvested material has been superior in quality and 
chemical composition in comparison to the commercially grown material. Over 
the recent years the quality has been improved through research and 
development. Further work still needs to be done in order for the two systems to 
match and by far the harvested material gives best and unique chemical 
qualities. 
 
Harvesting is done for a portion of the total required stock for Aloe and 
Pelargonium only, the rest of the supply is grown commercially under irrigation. 
The commercial growing method is costly but sustainable. The production is 
sustainable and environmentally sound due to crop production method used 
instead of the harvesting. The harvesting is being done, because most of the 
plant material has been there for many years. 
 
5.3.3  Processing Section of the Value chain 
The processing is done on site for all the South African patented products and 
some of the material is produced under licensing for international pharmaceutical 
companies. There are some materials that are sold to large international 
pharmaceutical who inturn manufacture products offshore but are sold in the 
domestic market. The final product is manufactured in Europe(EU) while the 
domestic products consist of the unique medicinal qualities of Pelargonium which 
is sourced from the Eastern and Western Cape provinces. The products are now 
gaining prominence in Asia especially the South African patented cough mixture 
products made from Pelargonium. For the cough mixture the final products are 
processed locally. The extraction for international patents are being licensed in 
the EU, but the products are made here. For the extraction for products 
manufactured oversees the crude active ingredients are sold in bulk and shipped 
to that market. For the other cosmetic products, the final goods are made in 
Europe especially for rooibos. The crude active ingredients are sent in 50kg 
drums to the EU. 
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5.3.4  Marketing Section of the Value chain 
Afriplex is an enterprise which is targeting domestic and international markets, 
although for the cough syrup the market is largely domestic. The international 
markets are potential but only focus on the raw active ingredient material instead 
of the finished product. For the cosmetic market the international market is more 
dominant; this is due to the superior product development and technology that is 
available internationally. Large pharmaceutical companies that operate in the 
anti-aging cosmetic market make use of the anti-oxidant properties in rooibos, 
the healing and soothing properties of Aloe. Domestic market has a cough syrup 
market predominantly. The percentage of the sales that are domestic for 
Pelargonium, Rooibos and Aloe: 50:50 local and international, although most of 
the product development is under licence there is a growing demand for 
pharmaceutical and cosmetic ingredients in the domestic market 
 
5.3.5  Distribution Section of the Value chain 
The domestic distribution is done via a company subsidiary and or the local 
network; for international customers it is done via special intermediaries and 
shipping companies. They are specialists in the shipping and trading of these 
products between South Africa and Europe. 
 
5.3.6  Final Product Section of the Value chain 
Afriplex is a crude supplier of active ingredients. Over time and intense research 
the Company has been able to sell a value added product and produce its own 
products. The biggest challenge has been the capital cost and the laboratory 
costs for research as some research cannot be done in South Africa but is still 
being outsourced to international laboratories. The final product is made in the 
EU by large pharmaceutical companies 
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5.4  Results of Small Medium Amarula Company interviews – Durban  
5.4.1  Introduction  
Everpix has the potential to turn over R10 million, and has operations in three 
provinces where the harvesting of MAPs occurs. The company buys dried nuts 
from rural communities led by women and Co-operatives (Cops). The company 
employs specially trained 16 youth workers to run a 24/7 oil processing 
operations at Pietermaritzburg. Workers are youth from Imbali, Edendale, rural 
Eastern Cape and rural Bulwer (KZN). The team is able to run operations without 
additional direct supervision according to set schedules and with some basic 
troubleshooting in the absence of direct supervision. A special machine for 
crushing the nut has been developed by the company.  
  
The Amarula Company; its rural community suppliers and workers thus set out to 
build a profitable industry reduce the vulnerability of South Africa’s rural 
households. Currently the communities have the natural resources but are not 
utilising them with overexploited natural systems, the negative impacts of climate 
change these resources will no longer exist. It is important that we care for the 
several million drought tolerant indigenous trees. The Amarula Company with a 
portfolio of novel African products that improves nutrition, health and wellness of 
local and global consumers. This company intervention is sustainable and could 
be replicated to other communities in South Africa and sub-Sahara in future.  
 
The objective of the company is creating a shared rural MAPs industry with 
Amarula. The nut inside the fruit, the waste from mechanical and manual fruit 
pulping, harbours one to four kernels which can be eaten and, contain a high 
value oil desired by the cosmetics industry; its nuts shells can find artisan, 
landscaping, industrial and fuel applications. Amarula Company (Pty) Ltd 
established a footprint in the Amarula value chain and a community supply 
network spanning 52-80 communities in Waterberg, Blouberg in Limpopo, 
Bushbuckridge, Mbombela and Nkomazi in Mpumalanga with expansion to 
Northern KZN. Amarula Company designed and commercially piloted proprietary 
high throughput mechanical nut to oil processing, doubled the income of 275 
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households for one month by purchasing Amarula nuts that are the waste of 
manual fruit pulping for beer brewing and are otherwise thrown away, sold 
Amarula nut oil overseas and attained sales forecasts for up to R10 Million in 
2013. Amarula Company is ready to formalize, grow and replicate its rural nut 
supply, produce more oil, expand its operations by integrating up and down 
stream and diversifying to other NTFP in future to capture substantially more 
value and share the benefits with rural suppliers and factory workers, create rural 
jobs and income and, plant NTFP trees for future income and household food 
security. For its substantial community and environmental benefit the Amarula 
Company – African Conservation Trust - community partnership received the 
2011 SEED Award from the UNDP, UNEP and IUCN SEED Initiative. SEED 
awards few global entrepreneurs annually which enterprises show large social 
and environmental benefit and exhibit the potential to replicate. 
5.4.2  Production Process Section of the Value chain 
There are two methods, harvesting for the Amarula fruit only, because there are 
no commercially grown trees currently. The company indicated that, in future it 
would grow the trees commercially. Harvesting is the only method of securing 
feedstock. The participants felt that this sourcing is sustainable environmentally, 
because  they are of the opinion that most of the trees have been there for many 
years, but recently the unique softwood of the tree is being used for furniture and 
toys. 
5.4.3  Processing Section of the Value chain 
The MAPS are processed on site and elsewhere, the Amarula is processed 
partially on site for beer production and 300km away for the oil manufacturing. 
The final product is manufactured in Europe pharmaceutical and cosmetic 
companies. For the beer, the processing of the beer is done after the extraction 
of the pulp and it is consumed within 20km radius of production. For the oil and 
other cosmetic products, the final good is manufactured in Europe. Everpix sells 
the oil in crude form and are sent in 50kg drums to the EU. 
5.4.4  Marketing Section of the Value chain 
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For the beer Amarula is a locally brewed and locally consumed beer. The market 
for the beer is traditionally opened for three months of the active harvesting and 
processing of the pulp and it is a domestic market. For the oil the market for 
Amarula oil is a high end cosmetic market in Europe. Recently the domestic 
market for the oil and its product has started to take off due to the uniqueness of 
the oil and its medicinal and aromatic properties. For Beer the market is 100% 
local and for Oil 95% international. 
 
5.4.5 Distribution Section of the Value chain 
The beer is sold directly to communities within 20km radius of the brewer; albeit 
it is an informal market the tradition is very strong and therefore sustainable due 
to the taste and seasonality of the beer. For the oil, the shipping of the oil is done 
via special cosmetic oil intermediaries and shipping companies. There are 
specialists in the shipping and trading of these products between South Africa 
and Europe. 
5.4.6  Final Product Section of the Value chain 
Beer is the final product for the local communities and they separate the kernel 
and dry it for collection and processing and in the oil it’s an input to the final 
product. The final product is made in the EU by large pharmaceutical companies. 
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Figure 6: Value Chain Chart of the Pelargonium plant in the study. 
 
Pelargonium plant Product 
Processing - Pelargonium root material is harvested 
from the wild by communities  
- Pelargonium is grown commercially and 
harvested similar to the wild harvesting- 
various projects with communities  
 
 
- Plant material is washed, cut and dried  
 
Final 
Products 
Tablets Capsules Effervescent Syrups 
- Material is extracted in a CGMP facility and formulated in liquids and powders  
- Research is done by academic institutions to show safety and efficacy 
 
 
Tinctures 
Distributors 
Retailers 
Chemists 
 
-Local consumption       -Local markets          -Local markets       - Local markets          -Local markets 
 
-Foreign markets        -Foreign markets       - Foreign markets    - Foreign markets    -Foreign markets 
Consumers 
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Figure 7: Value Chain of Amarula plant  
 
 
 
Product AMARULA FRUITS 
 
 
- Amarula fruit is 
picked off the 
ground when ripe  
-The fruits are 
sorted and hand-
washed and peeled 
by local women. 
-The fruits are 
processed into fruit 
pulp. 
-Fruits pulp is 
frozen into barrels. 
e.g Amarula Natural 
Products Pty Ltd 
Processing -Amarula 
fruit is 
picked off 
the ground 
when ripe 
-Pierce the 
skin 
-Cover the 
fruits and 
boil 
-Fermenting 
-Distillation 
-Wood 
matured 
-Remove the 
skins of the 
fruits. 
- Squeeze the 
fruit pulp, pip 
and juice out 
and add clean 
water. 
- Mash the fruit 
throughout till 
the liquid 
become thick. 
-Cover and 
leave for 2-4 
days. 
-Cracking of 
nuts of 
Amarula fruit 
-Decortication 
of nuts 
-Pressing 
kernels 
-Hand-pressing 
of kernels 
Amarula 
jam 
Amarula 
cream 
lacquer 
Homemade 
Amarula beer 
Amarula oil 
Final 
products 
-Fresh fruit pulp  
-Fruit pulp juice 
-As a seasonal 
flavour 
-Amarula Natural 
Products Pty Ltd 
-Ceres 
-Retailers 
-Retailers 
Supermark
ets 
-Retailers 
Supermarket
s 
Women in the 
rural areas 
-Amarula Natural 
Products Pty Ltd 
-Retailers 
Distributors 
-Local consumption       -Local markets       -Local markets     - Local markets          -Local markets 
-Foreign markets           -Foreign markets      - Foreign markets           
Consumers 
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Figure 8: Value chain of buchu herb 
 
Product BUCHU HERB 
The Buchu herb takes 
about 5 years to grow 
from a seedling until 
it’s ready to undergo 
the extraction process 
-The leaves are 
handpicked and the 
raw organic material 
processed 
immediately 
 
 
Final 
products 
SPARKLING 
HERBAL WATER 
Processing 
UTI RELIEF 
CAPSULES 
JOINT HEALTH 
CAPSULES 
FIRST AID GEL 
Distributors -Retailers 
-Retailers 
-Chemist 
-Retailers 
-Chemist 
-Retailers 
-Chemist 
Consumers 
-Local consumption       -Local markets            -Local markets     - Local markets          -Local markets 
-Foreign markets       -Foreign markets     - Foreign markets    - Foreign markets       -Foreign markets 
Product 
                                                                    BUCHU OIL 
During this 
delicate vacuum 
distillation, steam 
is passed through 
the Buchu leaf 
over a period of 6 
hours, producing 
the finest quality 
Buchu oil 
 
-This 
patented 
extraction 
process 
yields up to 
1.5% of 
Buchu oil on 
processed 
material 
 
-The oil is then 
quality 
controlled, 
batched, gas 
chromatograph
ed 
 
 
 
- Buchu oil is 
extracted in 
a patented 
process that 
is 100 
percent 
natural and 
organic 
 
54 
 
CHAPTER 6 
 
6.0 DISCUSSION OF RESULTS OF THE STUDY 
 
6.1  Introduction  
This chapter analyses and discusses the results of value chain challenges and 
constraints of the three selected South African medicinal and aromatic plants 
industry as supplied by participants and sources used by the study. The chapter 
focused on information and data benefited from comprehensive triangulation of 
information coming from different sources and conclusions were drawn from all 
existing evidence. There are suggested strategies provided by the sources that 
can be employed to mitigate the respective challenges and constraints.  
 
6.2  Value chain Challenges and Constraints of the three selected South 
African MAPs industry  
The value chain challenges and constraints facing the three selected South 
African MAPs industry as identified by the study in respect of the various 
sections of the chain are presented in Table 3. 
 
Table 3: Results of consensus views of value chain challenges and 
constraints of the selected African MAPs by respondents and 
sources used by the study 
 
Section of value 
chain 
Challenges and 
constraints of the 
African medicinal and 
aromatic plants 
Suggested strategies that 
can be employed to 
mitigate the challenges and 
constraints 
1.0 
 
Production section 
challenges & 
constraints 
Poor quality and high 
costs of commercially 
grown materials 
Continuous scientific 
research for quality 
propagation of materials and 
efficient commercial 
production method 
Absence of efficient and 
sustainable conservation and 
cultivation methods 
 
Encourage cultivation of MAPs as 
field and horticultural crops in 
gardens and farms. 
Government departments 
concerned with conservation of 
water, vegetation/forest should 
prioritize MAPs 
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Ecological threat due to use 
of haphazard harvesting and 
inefficient, ineffective post-
harvest management 
practices 
 
The protection and 
conservation of medicinal and 
aromatic plants should take 
high priority on the agenda for 
natural resources 
management. Segregation 
and key species cultivation 
Little or no research on the 
improvement of the low-
yielding species and 
adaptation to farming 
production systems 
Investment in Bio-technology for 
the development of sustainable 
cultivars 
Poor agriculture and 
propagation methods 
Investment in Bio-technology 
for the development of 
sustainable cultivars. 
Promotion of good agro-
ecological practices and good 
propagation methods 
Lack of commercially 
grown materials e.g. 
Amarula   
The industrial production of 
plants and propagation for 
crop production is required 
2.0  
 
Procession section 
challenges & 
constraints 
Lack of high-tech local 
industries for processing 
hence of the MAPs 
materials are sold to 
international companies  
Promotion of high investment 
in establishing large 
pharmaceutical companies 
locally. Or product-line 
extension by local companies  
Inefficient processing 
techniques leading to low 
yields and poor quality 
products 
Improvement of processing 
techniques leading to high 
yields and high quality 
Poor quality control 
procedures 
Improved quality for  control 
procedures with continued 
investment in research 
High-energy losses during 
processing 
Efficient energy use during 
processing and packaging 
Lack of current good 
manufacturing practices 
Use good manufacturing 
practices for efficiency 
Lack of R&D on product 
and process development 
Improved R & D on product 
and process development 
3.0  
 
Marketing, 
distribution and final 
sections’ challenges 
& constraints 
Lack of local markets for 
some MAPs products, 
e.g. Amarula oil 
Targeted marketing for the 
EU and other pharmaceutical 
companies with competitive 
prices  
Lack of superior 
technology to develop 
internationally competitive 
MAPs products 
Improved R & D on product 
and process development  
Lack of access to latest 
technological and market 
information 
and Streamline market 
access information 
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South Africa and most 
developing countries do not 
provide institutional support 
and programmes for 
production supplies to 
promote MAPs production 
Improved R & D on seeds 
production, product and process 
development and streamline 
market access information via 
efficient support programmes 
Difficulty in preserving 
extracts from MAPs for longer 
storage limiting marketability 
 
Governments and private sectors 
should either develop or import 
reliable preservatives of medicinal 
extracts for extended shelf life 
Consumers of traditional 
medicinal plants pay very little 
prices to the 
producers/harvesters of 
MAPs. Very demotivating 
from profitability perspective 
Promotion of value-adding and 
improved/efficient marketing 
system from 
production/harvesting to final 
consumers  
    
4.0  
 
Aspects of skilled 
human resources,  
technology, 
information, value 
adding, facilities, 
infrastructure, 
equipment, 
patenting and 
legislation 
challenges & 
constraints 
Lack of MAPs oriented hi-
tech for species breeding, pre 
and post harvesting 
processes of MAPs 
Establish technology station to 
produce equipment 
Lack of trained personnel 
and equipment 
Targeted skills and training 
programmes 
Lack of infrastructure, 
electricity, transport and 
water in rural areas to 
facilitate or improve value 
adding at rural areas 
Government to accelerate the 
rural development 
programmes 
Lack of facilities to 
fabricate equipment 
locally 
Import of new technology and 
equipment 
 
Lack of appropriate 
technology for post-
harvest and pre-
processing purposes 
adapted productively and 
effectively 
Technology for post-harvest 
and pre-processing purposes 
adapted productively and 
effectively 
Most claims by many 
herbalists in South Africa and 
developing countries have not 
been verified scientifically  
 
Government of South Africa and 
those of developing countries can 
establish links with international 
pharmaceutical companies to 
scientifically test these claims by 
herbalists 
Lack of or high cots or 
cumbersome patency and 
legislative procedures 
Government to prioritize 
legislation and patency in 
order to develop the MAPs 
industry 
Source: based on own information/data from the study (2014) 
 
6.2.4 Absence of efficient, sustainable conservation and cultivation methods  
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Majority of the data/information sources pointed to the above challenge as one of the 
major ones and suggested the encouragement of cultivation of MAPs as field and 
horticultural crops in gardens and farms and that the government departments of 
developing countries concerned with conservation of water, vegetation/forest should 
prioritize MAPs. According to Kideghesho et al. (2006) the protection and 
conservation of medicinal and aromatic plants do not take high priority on the 
agenda for natural resources management and that government programmes give 
priority to agricultural and wildlife resources (www.blackherbals.com). By growing 
MAPs in the form of gardens and farms for primary agriculture will not only ensure 
proper farm management practices of the species but the prevention of threat of 
extinction of several MAPs species through use of haphazard harvesting and 
inefficient, ineffective post-harvest management practices. The primary production 
approach similar to production of staple crops may further lead to economic 
production levels of the MAPs to favour manufacturing; hence the prioritization of the 
protection and conservation of the MAPs by the concerned governments’ 
departments cannot be overstated, especially in the area of research and information 
availability. 
 
6.2.2 Challenges of low-yielding, poor quality outputs, poor adaptation to farming 
production systems and very little research and development  
Some of the major challenges among the results of the study were very low-
yielding species, poor quality outputs and poor processing methods. In addition, 
most of the MAPs do not adhere to modern agricultural propagation practices. 
Compounding the problems is that there is little or no research on the 
improvement of the low-yielding species and adaptation to farming production 
systems in most of the developing countries. Many of the data/information 
sources were of the view that the aforementioned challenges have not been 
given the desired priorities by the governments of South Africa and other Less 
Developed Countries (LDCs) in national investment, research and export 
development. South Africa and Least Developed Countries (LDCs) concentrate 
their research and development on staple crops such as maize, rice and wheat. 
The lack of attention from the various governments of the LDCs may be 
attributed to many reasons. Adotey et al. (2012) and Mohamed et al. (2013) 
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indicated the lack of scientific proof to the effect that the active elements in 
medicinal plants are valuable, not dangerous and effectual. This is very 
important for the medical field and the public to endorse the use of African 
medicinal plants as highly acceptable alternatives to western medications; and 
this will in turn induce more research and development investment from 
government and private sectors as well as international collaboration. However, 
methods to be used to evaluate the safety and effectiveness of traditional 
medicine are new challenges which have emerged in recent years. There is lack 
of research mainly in the improvement of high-yielding species and the 
adaptation of the species to gardening and farming cultivars for primary 
agriculture. In South Africa and many LDCs especially in Africa, there are very 
little local support for research and development of MAPs. Greater part of the 
little support available is usually obtained from external sources. The situation is 
often exacerbated by inadequate infrastructure/facilities such as water, 
electricity, transport and communication, as well as manpower, technical 
resources and financial capital for investment. Highly required are investment in 
biotechnology for the development of sustainable cultivars, more support for 
research and training activities for traditional medicine and the promotion of good 
agro-ecological practices and good propagation methods. The research and 
development recommendations suggested will be more attainable if supported 
with the proper policies.   
6.2.3  Domination by manual practices with very little modern product 
manufacturing processes and lack of appropriate technology for post-harvest 
and pre-processing purposes   
 
Most of the respondents of the study agreed that traditional herbal medicines and 
aromatic products are formed by the practitioner him/herself who identify and 
harvest the right plant species. Thus in most cases the practitioner is the only 
one who knows the right species, he does the harvesting himself, and do the 
preparation of the medicines himself; all the processes done manually. Since all 
the processes are done manually, there is no guarantee of the genuineness, 
concentration levels of the potential elements in the herbal medicines and 
quantity of plant material used in the preparations. There are so many 
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differences in traditional medicines so produced in respect of quality. 
Determining the right medicinal concentrations, dosage and removal of toxic 
contents require highly efficient modern technologies. These are critical 
challenges to the realization of the full potential of the MAPs as alternative to 
western medicines. Therefore the need for investment by South Africa and LDCs 
for efficient and effective techniques, manufacturing practices and appropriate 
technology for post-harvest and pre-processing purposes for African medicinal 
and aromatic plants cannot be over-emphasized.  
6.2.4   Marketing of products challenges  
 
Marketing involves the movement of goods and services from the producer to the 
final consumers. In every commercial production or service the market is the 
main determinant of sustainability. No matter how much bountiful production is, 
the market is the adjudicator. The market outlets can be for local use or export. 
Some of the marketing challenges of the selected MAPs identified by the study 
include:  
- Inability of producers/harvesters to have contract agreements for supply 
due to lack of volume that can be produced by small industries 
- Inability to access market information 
- poor preservation of medicinal extracts for extended shelf life and 
- low prices paid for traditional medicinal plants by herbal medicine traders 
and urban herbalists 
According to Agricultural Marketing Resource Centre (2007) marketing is not just 
about selling but requires a clear and perfect understanding of what consumers 
want and the ability to deliver it to them through the most appropriate channels 
for a profit. The marketing functions comprise identifying the target market, 
product design, pricing, promotion, transportation (distribution), storage, and 
financing. Selling directly to retail outlets requires a routine sales route as well as 
an adequate volume of the product to meet market demand. Large volumes are 
required in wholesaling; they should be provided over a longer period of time in 
order to have consistency and guaranteed supply. These volumes will require 
grading and packaging facilities on site. There are further requirements for 
standards on quality, grade and size which are necessity in wholesale and retail 
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markets. Unforeseen risks may limit production and profitability of African 
medicinal and aromatic plants. Unstable markets, low product prices, changing 
tastes, poor infrastructure, droughts, inadequate government policies, longer 
food preparation time, as well as competition from non-African medicines and 
aromatic products are common risks faced by these plant-based industry 
markets. Government’s support in the form of market information availability to 
the suppliers and buyers in this industry would go a long way in improving the 
marketing of the plant-based industry. Good preservation of African medicinal 
and aromatic extracts for extended shelf life will help reduce losses and also 
spread supply and maintain prices across seasons.  
Regarding export market, usually medicinal plants are allowed without any tariff 
restrictions in many countries. According to Zhang (1998) the medicinal plants 
are mostly exempted from import duty in Canada, Japan, the European Union 
and the USA. However, tariff charges in China and South Africa vary between 
10% and 20% of the value of goods, depending on product and origin, while 
Japan levies a 5% tax on imports of ginseng roots, peppy straw, sandalwood and 
some others (Zhang, 1998). Threats to the future development of medicinal plant 
exports from South Africa and LDCs depend on the structure of the major 
importing markets.  
Efficient and effective marketing of MAPs especially in the high valued 
international markets requires strong marketing infrastructure and R&D facilities. 
Such capitals are usually not easily available in South Africa and most of the 
developing countries. The other challenge identified by most of the sources of 
the study is that herbal medicines are not sold as over-the-counter products in 
the developed countries hence the need for capital investment in R&D, post-
harvest technology and quality products’ processing, packaging and storage 
infrastructure.  
 
Currently South Africa and most of the LDCs are not cultivating the MAPs. Most 
of the suppliers are actually harvesters of the MAPs from the wild. As indicated 
by some of the respondent companies, the quality of some of few commercially 
grown cultivars leaves much to be desired. Therefore the supply potential is thus 
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virtually unknown. Another major challenge as indicated by most of the sources 
of the study is the lack of high-tech know-how in processing technologies, lack of 
regular supplies of plant raw materials in adequate quantities on long-term basis, 
unavailability of sustainable production processes, lack of institutional capability 
to advice on quality requirements of standardized plant extracts, policy and 
regulatory mechanisms.   
Regarding policy from the South African perspective, medicinal products are 
controlled by legislation in the medicines and Related Substances Control Act 
[No.101 of 1974], including the Pharmacy Act [No.53 of 1974] and their related 
regulations and Ethical Rules. The Medicinal Control Council (MCC) is the 
primary agency in South Africa responsible for control, regulation and registration 
of all medicine. The legislative approach for herbal medicines only makes 
accommodation of registration of medicines in two categories: orthodox and 
veterinary medicines (Parliamentary Act, 1998). Homeopathic medicine is dealt 
with under the orthodox category, but complementary medicines, which included 
African traditional medicine was not adequately covered. African traditional 
medicine has now been removed from this category and the MCC is reviewing 
the legislation. Section 14 of the medicines and Related Substance Control Act 
stipulates that no person shall sell any medicines that need to be registered, 
unless that medicine has already been registered (Parliamentary Act, 1998). The 
MCC has accepted the following understanding of herbal medicine for the 
purpose of registration. 
 
Herbal medicines are finished, labelled medicinal products that contain an active 
ingredient aerial or underground parts of plants or other plant material or 
combination thereof, whether in the crude state or as plant preparation. A herbal 
medicine does not include medicines used exclusively in formalized Herbalism or 
in traditional indigenous herbalist practices. Any company manufacturing 
registered medicinal products is required to be a pharmaceutical company 
registered with the MCC, as well as with the South Africa Pharmacy Council.  In 
1994, the WHO Regional Office for the Eastern Mediterranean published 
Guidelines for Formulation of National Policy on Herbal Medicines (WHO, 2002-
5). As the majority of the world population seeks treatment with traditional 
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medical practices, especially herbal medicine, and as herbal medicines are of 
particular value in gastrointestinal problems, upper respiratory tract ailments, 
urinary tract diseases and skin diseases, the need to formulate national policies 
on traditional medicines and to encourage co-operation between Member States 
in this regard is evident (Zhang, 1998). 
 
In Africa the use of herbal medicine is based on the traditional knowledge and 
belief. However, knowledge about herbal medicines is very limited in most of the 
developed countries. This limits the usage, consumption and marketability of the 
plants. It is therefore important to employ a  special deliberate systematic 
approach or strategy to link with end-users in the developed countries to study 
their use in herbal supplements and herbal remedies manufactured by them, 
explore the possibility of selling traditional herbal supplements and tonics and 
lastly, to examine the requirements for marketing traditional medicines.  
 
Last but not the least of the marketing challenges is the lack of value adding to 
the African Medicinal and Aromatic Plants preparations. It is an established fact 
that value-adding improves income from the products, however majority of 
primary producers of herbal medicines in Africa have not as yet moved towards 
adding value to local natural products. Gurib-Fakim (2005) and Rukangira (2001) 
indicated that some plants originating from Africa have become sources of 
important drugs with examples extending to Neostigmine which is made from the 
Calabar bean being used in treating glaucoma and as an insecticide. 
 
6.2.5    The intellectual property challenge  
 
The study also found that intellectual property rights of traditional medicines continue 
to be one of the major concerns in South Africa and the Less Developed Countries. It 
is very difficult for them to be patented because the plants have been used by many 
people in many traditional medicines for many years from generation to generation; 
however, they can be registered as individual or regional trademarks, with 
unequivocal directions of source. The hindrance to patenting of the African traditional 
medicines in South Africa and LDCs are many and varied which include: 
nonexistence of legislative framework for official recognition of African herbal 
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medicines and their registration and property rights procedures; lack of knowledge 
about intellectual property rights; high cost of patenting to the African and their 
institutions; lack of patent experts to advise on requirements for patenting; and the 
fact that plant materials cannot be patented in their natural form. According to Wilder 
(2001) traditional healers associations have identified the high costs of filing patent 
applications as the biggest obstacle to the acquisition of patents by practitioners of 
traditional medicines. According to the report by the World Intellectual Property 
Organisation (2001), holders of indigenous knowledge systems pointed out that the 
transaction costs of the formal system are beyond the capacity of the majority of 
informal innovators, hindering their ability to file for patents. Although it is true that 
plant materials cannot be patented in their natural form, efforts should be made to 
protect the processes involved in the development of herbal medicine and aromatic 
products as well as the novel uses of the products.                                  
 
6.2.9  Lack of access to information 
The study also identified lack of access to information as one of the challenges 
limiting the development of the African herbal medicine industry. International 
databases and journals form the major sources of literature for many researchers 
and knowledge seekers of African herbal medicines and aromatic plants. 
However, due to lack of finance and other economic priorities they do not 
subscribe to these sources for data and information. It should be emphasized 
that critical information/data required for technologies and scientific processing of 
herbal medicines and aromatic plants are not available at the aforementioned 
sources; many of the sources that contain such important data and information 
are usually patented and require money to be granted access. 
6.2.10 Human resource development challenge 
More highly qualified specialists in chemical engineering and technology are 
required if appropriate and proper scientific research in African herbal and 
aromatic plants are to be undertaken. However, very few scientists in Africa 
specialize in this field; the services of the few specialists available are also 
required in other similar industrial sectors, making it a major limitation to the 
industry’s development. 
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6.2.11 Pressure on the ecology 
The majority of the focus groups and other respondents indicated that the major 
concern facing African medicinal and aromatic plants’ continuous availability, 
development and use is its survival and reproducing ability for future supply 
needs. In most of the LDCs the herbal medicinal and aromatic plants usually 
grow in the wild and harvested without restrictions by traditional herbal medicine 
practitioners. The plants are harvested sometimes for commercial use; some of 
the harvesting procedures used are destructive especially where shoots and 
underground parts are removed incorrectly and become vulnerable to higher 
temperatures; this may disrupt or curtail the photosynthetic activities of the 
affected plants (Kala et al., 2006) (www.ethnobiomed.com). Lange (2004) 
reported severe decline in herbal medicinal plants in many parts of the world and 
attributed it to the demand in international trade and not to the supply needed by 
the indigenous population. The trade in botanicals is largely unmonitored 
(www.lib.teiep.gr). This over-exploitative practice without primary cultivation of 
the plants for regeneration coupled with other factors such as climate change, 
desertification, bush fires, drought and population growth will cause drastic 
decline of African medicinal plant resources’ genetic diversity and livelihoods of 
people who depend on plants. Phondani (2011) indicated that demand for 
medicinal plant-based raw materials is growing and many African medicinal plant 
species are each used in curing more than one disease (www.lib.teiep.gr).   
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CHAPTER 7 
 
7.0  CONCLUSIONS AND RECOMMENDATIONS 
 
7.1  Introduction 
This chapter summarizes the research findings and arrives at conclusions based 
on results of the study and puts forward some recommendations which are 
believed to be of benefit to the MAPs Amarula (Sclerocarya birrea), Buchu 
(Agathosma betulina), and Pelargonium (Pelargonium sidoides industry 
especially in the study area. 
 
7.2  Conclusions 
Medicinal and Aromatic plants extracts have become an essential part of exports in 
the developing countries. The preference by consumers to have natural products has 
grown over the years, this increases annually and has allowed medicinal,  aromatic 
plants to present a unique and niche market  base for pharmaceuticals, cosmetics 
and other industries (food & industrial use). South African farmers can exploit this 
new industry in order to grow the sector, create jobs and economic development as 
well as balance of payment. The cost of setting up a full value chain industry for 
MAP’s includes major investment in research and development in order for the 
country to best utilise its natural resource despite these hegemonic challenges 
discussed. South African researchers, leaders and its government institutions need 
to focus on indigenous plant research projects in order to assist the country with job 
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creation. Support for a study like this should be promoted to preserve the traditions 
and commercialise these practices. 
 
The objective of the study was to identify and analyse the value chain challenges 
and constraints militating against the economic development potential of three 
selected MAPs in South Africa. The study employed holistic and participatory 
approaches to comprehensively examine all aspects that relate the three 
selected MAPs industry in South Africa especially in the study areas. The study 
benefited from triangulation of qualitative data gathered from previous research 
and reports, interviews, focus group discussions and industry visits observations. 
Key government units relating to agricultural medicinal and aromatic industry 
were also consulted and reports used to verify findings from focus group 
discussions. Thus, the study used both secondary and primary information/data. 
The research made use of secondary data from review of literature through a 
desktop study of published and unpublished resources. Secondary information 
was also gathered from annual reports from the Agritex office, non-governmental 
organizations, research institutions and academic work of individuals. The 
information gathered from the desk review was also used to inform the selection 
of the sites for conducting focus group discussions and mapping the various key 
informants to be interviewed. This also informed the research in terms of existing 
information gaps and the identification of areas for further investigation.  
 
Focus group discussions were used to gather primary information/data from key 
stakeholders in the industry in South Africa. The focus group discussions were 
held in three provinces inter allia Kwa-Zulu-Natal, Mpumalanga and the Western 
Cape using a semi-structured guide. All the data from focus group discussions, 
key informant interviews, secondary data and field visit observations was 
consolidated and analysed using the SPSS computer programme and Atlas 
software. Information from the key informants’ interviews was used to triangulate 
information gathered from the desktop review and focus group discussions. The 
main value chain constraints and challenges identified and analysed by the study 
include:  
 Poor quality and high costs of commercially grown materials 
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 Absence of efficient and sustainable conservation and cultivation methods 
 Ecological threat due to use of haphazard harvesting and inefficient, 
ineffective post-harvest management practices 
 Little or no research on the improvement of the low-yielding species and 
adaptation to farming production systems 
 Poor agriculture and propagation methods 
 Lack of commercially grown materials e.g. Amarula   
 Lack of high-tech local industries for processing hence of the MAPs 
materials are sold to international companies  
 Inefficient processing techniques leading to low yields and poor quality 
products. 
 Poor quality control procedures. 
 High-energy losses during processing. 
 Lack of current good manufacturing practices. 
 Lack of R&D on product and process development. 
 Lack of local markets for some MAPs products, e.g. Amarula oil 
 Lack of superior technology to develop internationally competitive 
MAPs products 
 Lack of access to latest technological and market information 
 South Africa and most developing countries do not provide institutional 
support and programmes for production supplies to promote MAPs 
production 
 Difficulty in preserving extracts from MAPs for longer storage limiting 
marketability 
 Consumers of traditional medicinal plants pay very little prices to the 
producers/harvesters of MAPs. Very demotivating from profitability 
perspective 
 Lack of MAPs oriented hi-tech for species breeding, pre and post 
harvesting processes of MAPs 
 Lack of trained personnel and equipment 
 Lack of infrastructure, electricity, transport and water in rural areas to 
facilitate or improve value adding at rural areas 
 Lack of facilities to fabricate equipment locally. 
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 Lack of appropriate technology for post-harvest and pre-processing 
purposes adapted productively and effectively 
 Most claims by many herbalists in South Africa and developing countries 
have not been verified scientifically  
 Lack of or high costs or cumbersome patency and legislative 
procedures 
 
 
 
 
7.3 Recommendations  
Important recommended strategies are that: 
 Government should come out with clear agricultural policies to establish an 
information centre that acts as a source of information for producers and 
harvesters of MAPs  
 Government should work on technical issues concerning African medicinal 
and aromatic plants such as; promoting the use of research and experts on 
issues regarding the marketing of the products.  
 Initiatives from rural and peri-urban community towards African medicinal and 
aromatic plants should be supported by appropriate assistance from 
institutions by providing adequate extension services, improving grants, and 
access to credit inputs. This call for policy proposals that could help address 
the challenges faced by the marketing of the products from MAPs. The need 
for improvement in access to markets and market information with respect to 
African medicinal and aromatic plants should be one of the priorities of 
government.  
 
 Government should assist in human resource development through 
mobilization, facilitation and integration of a comprehensive market strategy 
that will enable African medicinal and aromatic plants producers/harvesters to 
have greater access to national and international markets. One of the vital 
69 
 
necessities of a successful agricultural sector is the availability of reliable, 
readily available and understandable market information. This enhances 
producers' decision making and afford them a chance to exploit market 
opportunities. With the current deregulation of the various control boards, 
timely market information has become even more important as producers will 
now have to be more involved in marketing of their produce.  
 
 The balance between marketing of inputs and production is vital to guard 
against the cost price-squeeze syndrome. Supply-side measures help reduce 
the costs price-squeeze syndrome   and lead to sustainable growth of the 
manufacturing sector. Some of these measures are;  
 Support for technological development and diffusion:  
 Support for skill development of producers especially young 
aspiring producers  
 Competitive input prices;  
 Support programmes with respect to infrastructural 
development; and  
 Promotion of both internal and export marketing programs.  
 For production to be effective, the current extension services should be 
enhanced and given an independent unit with the objective of;  
 Awareness on African medicinal and aromatic plants   
 Market coordination with respect to African medicinal and 
aromatic plants 
 Information centre and  
 Capacity building, especially for young producers  
 The government is expected to facilitate the creation of new opportunities for 
the established and new entrant producers by developing support systems 
and infrastructure and by the provision of training, marketing information and 
other support services.  
 
7.4  Implications for further research  
Support for a study like this should be promoted and furthering of the study at 
doctoral level is advised. During the study the researcher in this study 
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necessitates the identification of personal values, assumptions and biases at the 
outset of the study. The primary researcher used her mother tongue Xhosa 
assisted in working with the key participants. Although every effort was made to 
ensure objectivity, the researcher’s personal bias could shape the way she views 
and understands the development of further research for the dissertation. The 
primary researcher believes that these experiences enhance knowledge and 
sensitivity to the issues being addressed in this study and will assist South Africa 
in planning for the use of commercialising MAPs. She recognizes the need to be 
open to the thoughts and opinions of others and has set aside her experiences in 
order to understand those of the participants in the study. 
 
 
REFERENCES 
Adotey, J.P.K., Adukpo, G.E., Boahen, Y.O., Armah, F.A. (2012). A Review of 
the Ethno botany and Pharmacological Importance of Alstonia boonei De Wild 
(Apocynaceae). ISRN Pharmacol, 2012: 587160.   
 
Agricultural Marketing Resource Center (2007). Direct Marketing of Agricultural 
Produce; lesson 3, value-added Agricultural Profile. Iowa State University. 
 
Niekerk, A. (2005). Ethics in Agriculture - An African Perspective, Springer 
Science & Business Media, 2005 ISBN 1402029888, 9781402029882 a nation of 
immigrants, retrieved, 09, January, 2014. 
 
Bagley, M.A. (2003). Patently Unconstitutional: The Geographical Limitation on 
Prior Art in a Small World. 
 
Bagley, M.A. (2003). Patently Unconstitutional: The Geographical Limitation on 
Prior Art in a Small World. 
 
Bell, T. (1984). Unemployment in South Africa. Occasional Paper 10. The 
Institute of Social and Economic Research, University of Durban Westville, 
Durban. 
 
Van Wyk, B. Van Oudtshoom, B. Nigel, G. (2012). Medicinal Plants of South 
Africa 2012  Briza Publications, 2012 ISBN 1875093370, 9781875093373 
 
71 
 
Bodeker, G. and Masood, E. 1997 Medicinal plants threatened by over-use. 
Nature, February 1997, vol. 385, no. 6617, p. 570. 
 
Bless C., and Higson, S.C., 1995. Fundamentals of Social research methods: An 
African perspective. Kenwyn: Juta. 
 
Diederichs, N. (2005). Commercialization of Medicinal Plants, A South African 
Guide, First Edition, Edited by Nicci Diederichs 
 
De Silva, T. (1997). Industrial utilization of medicinal plants in developing 
countries.In: BODEKER, G.; BHAT, K.K.S.; BURLEY, J. and VANTOMME, P. 
eds. Medicinal plants for forest conservation and health care. FAO, Non-wood 
Forest Products Series No. 11, FAO, Rome, 1997, p.34 -158. 
 
Dhar, U.; Manjkhola, S.; Joshi, M.; Bhatt, A. and Joshi, M. (2002) Current status 
and future strategy for development of medicinal plants sector in Uttranchal, 
India. Current Science, October 2002, vol. 83, no. 8, p. 956-964. 
 
DST, (2014.) Department of Science and Technology BioEconomy Strategy 
 
Emeka, U., Iloegbunam, N.G., Gbekele-Oluwa, A.R., Bola, M. (2014).  Natural 
Product Research Issues, Opportunities and Current Priorit ies in Nigeria. Inter J 
Natural Products Res, 4(1): 19-32. 
Ethnopharmacology, September 2003, vol. 88, no. 1, p. 19-4 
 
Gupta, R., Gabrielsen, B., Ferguson., S.M. (2005). Nature's Medicines: 
Traditional Knowledge and Intellectual Property Management. Case Studies from 
the National Institutes of Health (NIH), USA. Curr Drug Discov Technol, 2(4): 
203-219. 
 
Gurib-Fakim, A. (2005).  Review Medicinal plants: Traditions of Yesterday and 
Drugs of Tomorrow; Faculty of Science, University of Mauritius, Reduit, Maurit ius 
2005 Elsevier Ltd. 0098-2997.http://www.tradeportalofindia.com 
/usrdata/webadmin/Section3.9/HS12_Medicinal AromaticPlants_ITPOFft.html 
Retrieved October 01, 2013.  
 
Industrial Policy Action Plan (IPAP). (2010). Government of South Africa,   
Department of Trade and Industry. 
 
Industrial Policy Action Plan (IPAP). (2011). Government of South Africa,  
Department of Trade and Industry. 
 
72 
 
ITPO. (2001). India Trade Promotion Organisation Publications on Medicinal 
Aromatic Plants Export Report published by the Government of India.   
 
Jump up^ Li, Wen-Hsiung; Dan Graur (1991). Fundamentals of Molecular 
Evolution. Sinauer Associates. p. 29.ISBN 0-87893-452-9. 
 
Kala, C.P., Dhyani, P.P., Sajwan, B.S. (2006). Developing the Medicinal Plants 
Sector in Northern India: challenges and opportunities. Journal of Ethnobiology 
and Ethnomedicine 2006, 2:32. 
 
Kideghesho, J.R., Nyahongo, J.W., Shombe, N.H., Tarimo, T.C., Mbije, N.E. 
(2006). Factors and Ecological Impacts of Wildlife Habitat Destruction in the 
Serengeti Ecosystem in Northern Tanzania. AJEAM-RAGEE, 11: 917-932. 
 
Leedy, P.D and Ormrod, (2010) J.E, Practical research: Planning and design, 
Ninth edition, Pearson. 
 
Lange, D. (2004). Medicinal and Aromatic Plants: Trade, Production, and 
Management of Botanical Resources Proc. XXVI IHC – Future for Medicinal and 
Aromatic Plants. Acta Hort, 629: 177-197. 
 
Lange, D. (2006). International Trade in Medicinal and Aromatic Plants. In: R.J. 
Bogers, L.E. Craker and D. Lange (ed.) Medicinal and Aromatic Plants. Springer. 
Netherlands, p. 155-170. 
 
MASOOD, E. (1997). Medicinal plants threatened by over-use. Nature, February 
1997, vol. 385, no. 6617, p. 570. 
 
Medicinal Plants of Rural India: A Review of Use by Indian Folks Mohd. 
Mazid2012 *a, Taqi Ahmed Khanb, Firoz Mohammada a Advanced Plant 
Physiology Division, Department of Botany, Faculty of Life Sciences, AMU, 
Aligarh-202002, India Department of Biochemistry, Faculty of Life Sciences, 
AMU, Aligarh-202002, India Climate Risk Management in Africa: Learning from 
Practice. International Research Institute for Climate and Society (IRI), Columbia 
University, New York, USA. 
 
Mohamed, S.E., Azhari, H.E.E., Rasha, M.R., Mona, A.A. (2013).  
Pharmacological Investigations of Solenostemma Argel leaves. Global J Trad 
Med Sys, 2(1): 28-36.  
 
Mudau, F.N, Ngezimana, W. (2014).  Effect of different drying methods on 
chemical composition and microbial activities of bush tea (Athrixia phylicoides 
D.C.). Int J of Agric and Biol, 16(5):1011–1014. 
73 
 
 
Muhammad, B.Y., & Awaisu, A. (2008). The Need for Enhancement of Research, 
Development, and Commercialization of Natural Medicinal Products in Nigeria: 
Lessons from the Malaysian Experience. Afr J Traditional, Complementary and 
Alternative Medicines, 5 (2): 120-130.  
 
Mukherjee, P.K (2003). GMP for Indian Systems of Medicine. In: MUKHERJEE, 
P.K. and VERPOORTE, R. eds. GMP for Botanicals: Regulatory and Quality 
Issues on Phytomedicines, Business Horizons, New Delhi, 2003, p. 99-112. 
ISBN 81-900788-5-2. 
 
Mukherjee, P.K. (2002). Quality control herbal drugs: An approach to evaluation 
of botanicals, Business Horizons, New Delhi, 2002. 800 p. ISBN 81-900788-4-4 
 
Myles Mander, (1998). MARKETING OF INDIGENOUS MEDICINAL PLANTS IN 
SOUTH AFRICA A case study in Kwazulu-Natal by Myles Mander FOOD AND 
AGRICULTURE ORGANIZATION OF THE UNITED NATIONS-FAO Rome, 1998. 
 
Diederichs, N. (2006) Commercialising Medicinal Plants: A Southern African 
Guide edited ,AFRICAN SUN MEDIA, 
 
OECD, (2011), Agricultural Policy Monitoring and Evaluation 2011 OECD 
Countries and Emerging Economies.  
 
Oladele, A.T., Alade, G.O., Omobuwajo, O.R. (2011). Medicinal Plants 
Conservation and Cultivation by Traditional Medicine Practitioners (TMPs) in 
Aiyedaade Local Government Area of Osun State, Nigeria. Agric Bio J N Am, 
2(3): 476-487. 
 
Otieno, N.E., & Analo, C. (2012). Local Indigenous Knowledge about some 
Medicinal Plants in and around Kakamega Forest in Western Kenya. Res, 1:40. 
 
Parliament passed Act 132 of 1998 the South African Medicines and Medical 
Devices Regulatory Authority Bill. 
 
Phondani, P.C. (2011). Worth of Traditional Herbal System of Medicine for 
Curing Ailments Prevalent Across the Mountain Region of Uttarakhand, India. J 
Applied Pharmaceutical Sci, 1 (9): 81-86. 
 
Population connection. (2006).http://www.populationeducation.org/sites  
 
Ramakrishnappa, K. (2014). Impact of Cultivation and Gathering of Medicinal 
Plants on Biodiversity: Case studies from India. In: Biodiversity and the 
74 
 
Ecosystem Approach in Agriculture, Forestry and Fisheries [online], FAO, 2002 
[cited 25 March 2003]. Available from retrieved, 09, January, 2014. 
 
Rout, S.D., Panda, T., Mishra, N. (2009). Ethno-medicinal Plants Used to Cure 
Different Diseases by Tribals of Mayurbhanj District of North Orissa. Ethno-Med, 
3(1): 27-32. 
 
Rukangira, E. (2001). Medicinal plants and traditional medicine in Africa: 
Constraints and challenges. Sustainable Dev Inter 4, 179-184.  
 
Shah, S., Ram, J. Pala, N.A., Tripathi, P., Kumar, M. (2014).  Medicinal Plant 
Wealth of Oak Dominated Forests in Nainital Catchment Area of Uttarakhand. 
Academia J Med Plants, 2(1): 6-13. 
 
Tabuti, J.R.S.; LYE, K.A. and Dhillon, S.S.(2003). Traditional herbal drugs of 
Bulamogi, Uganda: plants, use and administration. Journal of 
Ethnopharmacology, September 2003, vol. 88, no. 1, p. 19-4. 
 
Ernerst Rukangira, (2013). THE AFRICAN HERBAL INDUSTRY: CONSTRAINTS 
AND CHALLENGES by Ernest Rukangira Director, Conserve Africa International 
Retrieved October 01, 2013. 
 
Tripathi, S., Ray, S., Mondal, A.K., Verma, N.K. (2013). Rare Ethno Medicinal 
Plants of South West Bengal, India with their Different Medicinal Uses: Needs 
Conservation. Int J Lifesci Bt & Pharm Res, 2(2): 114-122.  
 
Warren, E. (2004). Mathematical Population Genetics I. Theoretical 
 Introduction. Interdisciplinary Applied Mathematics. Springer-Verlag. 
 
Wilder, R. (2001). Protection of Traditional Medicine. ICRIER Working Paper No. 
66. Partner, Powell, Goldstein, Frazer & Murphy LLP Washington, D.C., USA.  
 
World Bank (2013), Global Value Chains, Economic Upgrading, and Gender. 
Case Studies of the Horticulture,Tourism, and Call Center Industries, Poverty 
Reduction and Economic Management Network, World Bank, Washington, DC. 
 
World Health Organization (WHO), WHO Traditional Medicine Strategy (2002-
200). Geneva, 2002 [cited 10 October 2003]. Portable Document Format. 
Available from. 
 
World Intellectual Property Organisation. (2001). Intellectual property needs and 
expectations of traditional knowledge holders. WIPO report on fact finding 
mission on Intellectual Property and Traditional Knowledge. Geneva.  
75 
 
 
Zhang, X. (1998). World Health Organisation publication: WHO/TRM/98.1: 
Traditional medicine programme Regulatory Situation of Herbal Medicines a 
Worldwide Review. 
 
 
